<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28208713</article-id><article-id pub-id-type="pmc">5331547</article-id><article-id pub-id-type="doi">10.3390/nu9020116</article-id><article-id pub-id-type="publisher-id">nutrients-09-00116</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Effects of an Encapsulated Fruit and Vegetable Juice Concentrate on Obesity-Induced Systemic Inflammation: A Randomised Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Williams</surname><given-names>Evan J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Baines</surname><given-names>Katherine J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Berthon</surname><given-names>Bronwyn S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>Lisa G.</given-names></name><xref rid="c1-nutrients-09-00116" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-09-00116">Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan NSW 2308, Australia; <email>evan.j.williams@uon.edu.au</email> (E.J.W.); <email>katherine.baines@newcastle.edu.au</email> (K.J.B.); <email>bronwyn.berthon@newcastle.edu.au</email> (B.S.B.)</aff><author-notes><corresp id="c1-nutrients-09-00116"><label>*</label>Correspondence: <email>Lisa.wood@newcastle.edu.au</email>; Tel.: +61-240-420-147</corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>2</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2017</year></pub-date><volume>9</volume><issue>2</issue><elocation-id>116</elocation-id><history><date date-type="received"><day>20</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>1</month><year>2017</year></date></history><permissions><copyright-statement>© 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><offsets xml_i="3087" xml_f="3500" txt_i="11" txt_f="420">Phytochemicals from fruit and vegetables reduce systemic inflammation. This study examined the effects of an encapsulated fruit and vegetable (F&amp;V) juice concentrate on systemic inflammation and other risk factors for chronic disease in overweight and obese adults. A double-blinded, parallel, randomized placebo-controlled trial was conducted in 56 adults aged ≥40 years with a body mass index (BMI) ≥28 kg/m</offsets><sup><offsets xml_i="3505" xml_f="3506" txt_i="420" txt_f="421">2</offsets></sup><offsets xml_i="3512" xml_f="4255" txt_i="421" txt_f="1156">. Before and after eight weeks daily treatment with six capsules of F&amp;V juice concentrate or placebo, peripheral blood gene expression (microarray, quantitative polymerase chain reaction (qPCR)), plasma tumour necrosis factor (TNF)α (enzyme-linked immunosorbent assay (ELISA)), body composition (Dual-energy X-ray absorptiometry (DEXA)) and lipid profiles were assessed. Following consumption of juice concentrate, total cholesterol, low-density lipoprotein (LDL) cholesterol and plasma TNFα decreased and total lean mass increased, while there was no change in the placebo group. In subjects with high systemic inflammation at baseline (serum C-reactive protein (CRP) ≥3.0 mg/mL) who were supplemented with the F&amp;V juice concentrate (</offsets><italic><offsets xml_i="4263" xml_f="4264" txt_i="1156" txt_f="1157">n</offsets></italic><offsets xml_i="4273" xml_f="5021" txt_i="1157" txt_f="1897"> = 16), these effects were greater, with decreased total cholesterol, LDL cholesterol and plasma TNFα and increased total lean mass; plasma CRP was unchanged by the F&amp;V juice concentrate following both analyses. The expression of several genes involved in lipogenesis, the nuclear factor-κB (NF-κB) and 5′ adenosine monophosphate-activated protein kinase (AMPK) signalling pathways was altered, including phosphomevalonate kinase (PMVK), zinc finger AN1-type containing 5 (ZFAND5) and calcium binding protein 39 (CAB39), respectively. Therefore, F&amp;V juice concentrate improves the metabolic profile, by reducing systemic inflammation and blood lipid profiles and, thus, may be useful in reducing the risk of obesity-induced chronic disease.</offsets></p></abstract><kwd-group><kwd>obesity</kwd><kwd>systemic Inflammation</kwd><kwd>fruit and vegetable concentrate</kwd><kwd>blood lipids</kwd></kwd-group></article-meta></front><body><sec id="sec1-nutrients-09-00116"><title><offsets xml_i="5244" xml_f="5259" txt_i="1905" txt_f="1920">1. Introduction</offsets></title><p><offsets xml_i="5270" xml_f="5393" txt_i="1921" txt_f="2044">The global epidemic of obesity, “globesity”, is rapidly becoming a major public health problem in many parts of the world [</offsets><xref rid="B1-nutrients-09-00116" ref-type="bibr"><offsets xml_i="5443" xml_f="5444" txt_i="2044" txt_f="2045">1</offsets></xref><offsets xml_i="5451" xml_f="5522" txt_i="2045" txt_f="2116">]. In the U.S., 78.6 million adults (35% of the population) are obese [</offsets><xref rid="B2-nutrients-09-00116" ref-type="bibr"><offsets xml_i="5572" xml_f="5573" txt_i="2116" txt_f="2117">2</offsets></xref><offsets xml_i="5580" xml_f="5644" txt_i="2117" txt_f="2181">]. Australia is not far behind, with 28% of adults being obese [</offsets><xref rid="B3-nutrients-09-00116" ref-type="bibr"><offsets xml_i="5694" xml_f="5695" txt_i="2181" txt_f="2182">3</offsets></xref><offsets xml_i="5702" xml_f="5875" txt_i="2182" txt_f="2355">]. Obesity develops due to high caloric intake and/or inadequate energy expenditure over time, with genetic susceptibility also likely to have contributed to obesity rates [</offsets><xref rid="B4-nutrients-09-00116" ref-type="bibr"><offsets xml_i="5925" xml_f="5926" txt_i="2355" txt_f="2356">4</offsets></xref><offsets xml_i="5933" xml_f="6132" txt_i="2356" txt_f="2555">]. Overweight and obesity are associated with an epidemic of many chronic diseases, including type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), stroke, hypertension and certain cancers [</offsets><xref rid="B1-nutrients-09-00116" ref-type="bibr"><offsets xml_i="6182" xml_f="6183" txt_i="2555" txt_f="2556">1</offsets></xref><offsets xml_i="6190" xml_f="6193" txt_i="2556" txt_f="2559">]. </offsets></p><p><offsets xml_i="6200" xml_f="6340" txt_i="2560" txt_f="2700">Obesity is characterised by chronic, low-grade systemic inflammation, due to the release of pro-inflammatory mediators from adipose tissue [</offsets><xref rid="B5-nutrients-09-00116" ref-type="bibr"><offsets xml_i="6390" xml_f="6391" txt_i="2700" txt_f="2701">5</offsets></xref><offsets xml_i="6398" xml_f="6399" txt_i="2701" txt_f="2702">,</offsets><xref rid="B6-nutrients-09-00116" ref-type="bibr"><offsets xml_i="6449" xml_f="6450" txt_i="2702" txt_f="2703">6</offsets></xref><offsets xml_i="6457" xml_f="6629" txt_i="2703" txt_f="2875">]. Adipose tissue from lean individuals contains small, insulin-sensitive adipocytes, as well as tissue-resident macrophages of the alternatively-activated phenotype (M2) [</offsets><xref rid="B6-nutrients-09-00116" ref-type="bibr"><offsets xml_i="6679" xml_f="6680" txt_i="2875" txt_f="2876">6</offsets></xref><offsets xml_i="6687" xml_f="6688" txt_i="2876" txt_f="2877">,</offsets><xref rid="B7-nutrients-09-00116" ref-type="bibr"><offsets xml_i="6738" xml_f="6739" txt_i="2877" txt_f="2878">7</offsets></xref><offsets xml_i="6746" xml_f="6956" txt_i="2878" txt_f="3088">]. With the development of obesity, adipose tissue becomes characterised by large insulin-resistant adipocytes accompanied by the presence of classically-activated macrophages (M1), which are pro-inflammatory [</offsets><xref rid="B6-nutrients-09-00116" ref-type="bibr"><offsets xml_i="7006" xml_f="7007" txt_i="3088" txt_f="3089">6</offsets></xref><offsets xml_i="7014" xml_f="7015" txt_i="3089" txt_f="3090">,</offsets><xref rid="B7-nutrients-09-00116" ref-type="bibr"><offsets xml_i="7065" xml_f="7066" txt_i="3090" txt_f="3091">7</offsets></xref><offsets xml_i="7073" xml_f="7207" txt_i="3091" txt_f="3225">]. Adipocyte hypertrophy and death, adipose tissue hypoxia and changes in immune cell populations alter adipokine secretory patterns [</offsets><xref rid="B8-nutrients-09-00116" ref-type="bibr"><offsets xml_i="7257" xml_f="7258" txt_i="3225" txt_f="3226">8</offsets></xref><offsets xml_i="7265" xml_f="7329" txt_i="3226" txt_f="3290">]. This process leads to the development of insulin resistance [</offsets><xref rid="B6-nutrients-09-00116" ref-type="bibr"><offsets xml_i="7379" xml_f="7380" txt_i="3290" txt_f="3291">6</offsets></xref><offsets xml_i="7387" xml_f="7389" txt_i="3291" txt_f="3293">].</offsets></p><p><offsets xml_i="7396" xml_f="7572" txt_i="3294" txt_f="3470">In obese individuals, adipose tissue produces and secretes adipokines, such as leptin and adiponectin, and pro-inflammatory mediators, including tumour necrosis factor (TNF)α [</offsets><xref rid="B9-nutrients-09-00116" ref-type="bibr"><offsets xml_i="7622" xml_f="7623" txt_i="3470" txt_f="3471">9</offsets></xref><offsets xml_i="7630" xml_f="7737" txt_i="3471" txt_f="3578">]. The production and release of TNFα is the first step in a cascade of pro-inflammatory mediator release [</offsets><xref rid="B10-nutrients-09-00116" ref-type="bibr"><offsets xml_i="7788" xml_f="7790" txt_i="3578" txt_f="3580">10</offsets></xref><offsets xml_i="7797" xml_f="7798" txt_i="3580" txt_f="3581">,</offsets><xref rid="B11-nutrients-09-00116" ref-type="bibr"><offsets xml_i="7849" xml_f="7851" txt_i="3581" txt_f="3583">11</offsets></xref><offsets xml_i="7858" xml_f="7933" txt_i="3583" txt_f="3658">]. TNFα is a mediator in energy metabolism, immune function and apoptosis [</offsets><xref rid="B12-nutrients-09-00116" ref-type="bibr"><offsets xml_i="7984" xml_f="7986" txt_i="3658" txt_f="3660">12</offsets></xref><offsets xml_i="7993" xml_f="8040" txt_i="3660" txt_f="3707">] and increases the activation of neutrophils [</offsets><xref rid="B13-nutrients-09-00116" ref-type="bibr"><offsets xml_i="8091" xml_f="8093" txt_i="3707" txt_f="3709">13</offsets></xref><offsets xml_i="8100" xml_f="8275" txt_i="3709" txt_f="3884">]. C-reactive protein (CRP) is another inflammatory mediator that is produced by both adipocytes and the liver, in response to cytokines, such as TNFα and interleukin (IL)-6 [</offsets><xref rid="B14-nutrients-09-00116" ref-type="bibr"><offsets xml_i="8326" xml_f="8328" txt_i="3884" txt_f="3886">14</offsets></xref><offsets xml_i="8335" xml_f="8400" txt_i="3886" txt_f="3951">]. CRP is also positively associated with the degree of obesity [</offsets><xref rid="B10-nutrients-09-00116" ref-type="bibr"><offsets xml_i="8451" xml_f="8453" txt_i="3951" txt_f="3953">10</offsets></xref><offsets xml_i="8460" xml_f="8461" txt_i="3953" txt_f="3954">,</offsets><xref rid="B11-nutrients-09-00116" ref-type="bibr"><offsets xml_i="8512" xml_f="8514" txt_i="3954" txt_f="3956">11</offsets></xref><offsets xml_i="8521" xml_f="8603" txt_i="3956" txt_f="4038">] and is an independent predictor of myocardial infarction risk, stroke and T2DM [</offsets><xref rid="B10-nutrients-09-00116" ref-type="bibr"><offsets xml_i="8654" xml_f="8656" txt_i="4038" txt_f="4040">10</offsets></xref><offsets xml_i="8663" xml_f="8665" txt_i="4040" txt_f="4042">].</offsets></p><p><offsets xml_i="8672" xml_f="8839" txt_i="4043" txt_f="4210">Toll-like receptors (TLRs) and nuclear factor-κB (NF-κB)-associated mechanisms have been proposed as primary molecular pathways mediating adipose tissue inflammation [</offsets><xref rid="B15-nutrients-09-00116" ref-type="bibr"><offsets xml_i="8890" xml_f="8892" txt_i="4210" txt_f="4212">15</offsets></xref><offsets xml_i="8899" xml_f="8922" txt_i="4212" txt_f="4235">]. TLRs activate NFκB [</offsets><xref rid="B15-nutrients-09-00116" ref-type="bibr"><offsets xml_i="8973" xml_f="8975" txt_i="4235" txt_f="4237">15</offsets></xref><offsets xml_i="8982" xml_f="9228" txt_i="4237" txt_f="4483">], a transcription factor and potent inducer of gene transcription of pro-inflammatory cytokines. A plethora of inflammatory pathways is activated in obesity with mechanisms, such as, phosphorylation of mitogen-activated protein kinases (MAPKs) [</offsets><xref rid="B16-nutrients-09-00116" ref-type="bibr"><offsets xml_i="9279" xml_f="9281" txt_i="4483" txt_f="4485">16</offsets></xref><offsets xml_i="9288" xml_f="9379" txt_i="4485" txt_f="4576">] and AMP-activated protein kinase (AMPK) activity modulating adipose tissue inflammation [</offsets><xref rid="B17-nutrients-09-00116" ref-type="bibr"><offsets xml_i="9430" xml_f="9432" txt_i="4576" txt_f="4578">17</offsets></xref><offsets xml_i="9439" xml_f="9653" txt_i="4578" txt_f="4792">]. Peroxisome proliferator-activated receptor-α (PPARα), a nuclear receptor primarily expressed in the liver and potent inducer of fat oxidizing genes, has also been reported to reduce adipose tissue inflammation [</offsets><xref rid="B8-nutrients-09-00116" ref-type="bibr"><offsets xml_i="9703" xml_f="9704" txt_i="4792" txt_f="4793">8</offsets></xref><offsets xml_i="9711" xml_f="9712" txt_i="4793" txt_f="4794">,</offsets><xref rid="B18-nutrients-09-00116" ref-type="bibr"><offsets xml_i="9763" xml_f="9765" txt_i="4794" txt_f="4796">18</offsets></xref><offsets xml_i="9772" xml_f="9774" txt_i="4796" txt_f="4798">].</offsets></p><p><offsets xml_i="9781" xml_f="9937" txt_i="4799" txt_f="4955">Systemic inflammation puts obese individuals at increased risk of chronic diseases that have an inflammatory pathology, including CVD, diabetes and cancer [</offsets><xref rid="B19-nutrients-09-00116" ref-type="bibr"><offsets xml_i="9988" xml_f="9990" txt_i="4955" txt_f="4957">19</offsets></xref><offsets xml_i="9997" xml_f="9998" txt_i="4957" txt_f="4958">,</offsets><xref rid="B20-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10049" xml_f="10051" txt_i="4958" txt_f="4960">20</offsets></xref><offsets xml_i="10058" xml_f="10249" txt_i="4960" txt_f="5151">]. Weight loss, achieved via energy restriction, is one approach, which has been shown to correct or improve the overall metabolic profile. Weight loss significantly reduces circulating CRP [</offsets><xref rid="B21-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10300" xml_f="10302" txt_i="5151" txt_f="5153">21</offsets></xref><offsets xml_i="10309" xml_f="10310" txt_i="5153" txt_f="5154">,</offsets><xref rid="B22-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10361" xml_f="10363" txt_i="5154" txt_f="5156">22</offsets></xref><offsets xml_i="10370" xml_f="10379" txt_i="5156" txt_f="5165">], TNFα [</offsets><xref rid="B21-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10430" xml_f="10432" txt_i="5165" txt_f="5167">21</offsets></xref><offsets xml_i="10439" xml_f="10440" txt_i="5167" txt_f="5168">,</offsets><xref rid="B22-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10491" xml_f="10493" txt_i="5168" txt_f="5170">22</offsets></xref><offsets xml_i="10500" xml_f="10501" txt_i="5170" txt_f="5171">,</offsets><xref rid="B23-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10552" xml_f="10554" txt_i="5171" txt_f="5173">23</offsets></xref><offsets xml_i="10561" xml_f="10562" txt_i="5173" txt_f="5174">,</offsets><xref rid="B24-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10613" xml_f="10615" txt_i="5174" txt_f="5176">24</offsets></xref><offsets xml_i="10622" xml_f="10623" txt_i="5176" txt_f="5177">,</offsets><xref rid="B25-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10674" xml_f="10676" txt_i="5177" txt_f="5179">25</offsets></xref><offsets xml_i="10683" xml_f="10697" txt_i="5179" txt_f="5193">] and leptin [</offsets><xref rid="B22-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10748" xml_f="10750" txt_i="5193" txt_f="5195">22</offsets></xref><offsets xml_i="10757" xml_f="10855" txt_i="5195" txt_f="5293">]. Indeed, for every 1 kg of weight lost, there is a corresponding reduction in CRP of 0.13 mg/L [</offsets><xref rid="B26-nutrients-09-00116" ref-type="bibr"><offsets xml_i="10906" xml_f="10908" txt_i="5293" txt_f="5295">26</offsets></xref><offsets xml_i="10915" xml_f="10978" txt_i="5295" txt_f="5358">], accompanied by improvements in systemic insulin resistance [</offsets><xref rid="B27-nutrients-09-00116" ref-type="bibr"><offsets xml_i="11029" xml_f="11031" txt_i="5358" txt_f="5360">27</offsets></xref><offsets xml_i="11038" xml_f="11039" txt_i="5360" txt_f="5361">,</offsets><xref rid="B28-nutrients-09-00116" ref-type="bibr"><offsets xml_i="11090" xml_f="11092" txt_i="5361" txt_f="5363">28</offsets></xref><offsets xml_i="11099" xml_f="11310" txt_i="5363" txt_f="5574">]. However, it is well accepted that achieving and maintaining weight loss is unattainable for some individuals. Hence, alternative approaches for improving the metabolic profile of obese individuals are needed.</offsets></p><p><offsets xml_i="11317" xml_f="11629" txt_i="5575" txt_f="5887">Many studies, in both humans and animals, demonstrate that the consumption of dietary bioactive compounds found in fruit and vegetables, such as polyphenols and carotenoids, is able to improve the metabolic profile and reduce the risk of chronic diseases via signalling pathways involving NF-κB, MAPKs and AMPK [</offsets><xref rid="B8-nutrients-09-00116" ref-type="bibr"><offsets xml_i="11679" xml_f="11680" txt_i="5887" txt_f="5888">8</offsets></xref><offsets xml_i="11687" xml_f="11977" txt_i="5888" txt_f="6178">]. A recent study in overweight individuals found that a two-fold increase in fruit and vegetable intake for 16 weeks significantly decreased body mass index (BMI) and supine systolic blood pressure and increased plasma concentrations of the antioxidants α-carotene, β-carotene and lutein [</offsets><xref rid="B29-nutrients-09-00116" ref-type="bibr"><offsets xml_i="12028" xml_f="12030" txt_i="6178" txt_f="6180">29</offsets></xref><offsets xml_i="12037" xml_f="12428" txt_i="6180" txt_f="6571">]. Another study found that supplementing healthy individuals with 500 g of strawberries, rich in vitamin C and anthocyanins, daily for one month improved the lipid profile by decreasing total cholesterol, low-density lipoprotein (LDL) cholesterol and triglycerides, as well as decreasing markers of oxidative stress, including plasma malondialdehyde, urinary 8-OHdG and isoprostane levels [</offsets><xref rid="B30-nutrients-09-00116" ref-type="bibr"><offsets xml_i="12479" xml_f="12481" txt_i="6571" txt_f="6573">30</offsets></xref><offsets xml_i="12488" xml_f="12926" txt_i="6573" txt_f="7011">]. There is also emerging evidence that supplements containing dietary bioactive compounds can provide similar benefits. A recent review, including 18 human trials with a total of 1363 adults, reported that fruit and vegetable concentrate supplements significantly increased serum levels of antioxidants (β-carotene, vitamins C and E), as well as folate. In addition, the supplements reduced homocysteine and markers of oxidative stress [</offsets><xref rid="B31-nutrients-09-00116" ref-type="bibr"><offsets xml_i="12977" xml_f="12979" txt_i="7011" txt_f="7013">31</offsets></xref><offsets xml_i="12986" xml_f="12989" txt_i="7013" txt_f="7016">]. </offsets></p><p><offsets xml_i="12996" xml_f="13341" txt_i="7017" txt_f="7362">In this study, we hypothesised that obesity-associated inflammation could be suppressed using a fruit and vegetable concentrate supplement. The aim of this study was to examine the effects of an encapsulated fruit and vegetable juice concentrate on systemic inflammation and other risk factors for chronic disease in overweight and obese adults.</offsets></p></sec><sec id="sec2-nutrients-09-00116"><title><offsets xml_i="13392" xml_f="13417" txt_i="7364" txt_f="7389">2. Materials and Methods </offsets></title><sec id="sec2dot1-nutrients-09-00116"><title><offsets xml_i="13470" xml_f="13488" txt_i="7390" txt_f="7408">2.1. Study Design </offsets></title><p><offsets xml_i="13499" xml_f="13626" txt_i="7409" txt_f="7536">This was a double-blinded, parallel, randomised, placebo-controlled trial in 56 subjects aged ≥40 years and with a BMI ≥28 kg/m</offsets><sup><offsets xml_i="13631" xml_f="13632" txt_i="7536" txt_f="7537">2</offsets></sup><offsets xml_i="13638" xml_f="13788" txt_i="7537" txt_f="7683">, recruited from March 2014 to September 2014. Subjects were randomised to receive a fruit and vegetable (F&amp;V) concentrate supplement (Juice Plus+</offsets><sup><offsets xml_i="13793" xml_f="13794" txt_i="7683" txt_f="7684">®</offsets></sup><offsets xml_i="13800" xml_f="13836" txt_i="7684" txt_f="7720"> Orchard, Garden and Berry Blends) (</offsets><italic><offsets xml_i="13844" xml_f="13845" txt_i="7720" txt_f="7721">n</offsets></italic><offsets xml_i="13854" xml_f="13873" txt_i="7721" txt_f="7740"> = 28) or placebo (</offsets><italic><offsets xml_i="13881" xml_f="13882" txt_i="7740" txt_f="7741">n</offsets></italic><offsets xml_i="13891" xml_f="15193" txt_i="7741" txt_f="9043"> = 28) for 8 weeks. Subjects commenced a low fruit and vegetable diet (≤3 serves per day of fruit and vegetables combined) two weeks before randomisation as a washout period, and continued this diet for the duration of the study. Subjects were assessed at commencement of the study (Week 0) and again after supplementation (Week 8) at the Clinical Trials Facility at the Hunter Medical Research Institute. At both visits, anthropometric measures, blood pressure, pulse wave velocity and body composition were measured, and blood samples were collected. Subjects were non-smokers and had an absence of or irregular menses if they were female. Subjects were excluded if they were unwilling or unable to limit the intake of fruit and vegetables to no more than 3 servings/day, if they had used dietary or nutritional supplements within the previous 4 weeks, if they were current smokers, were currently participating in a weight management program or actively attempting to lose weight, were currently using any medication known to significantly influence inflammation, had an allergy to the supplement ingredients or chronic excessive alcohol consumption, which is associated with a high risk of chronic health problems, defined as ≥43 standard drinks per week for men and ≥29 drinks per week for women [</offsets><xref rid="B32-nutrients-09-00116" ref-type="bibr"><offsets xml_i="15244" xml_f="15246" txt_i="9043" txt_f="9045">32</offsets></xref><offsets xml_i="15253" xml_f="15468" txt_i="9045" txt_f="9257">]. Unused capsules were collected at the end of the study to determine adherence with the intervention. Participants with adherence of &gt;85% were included in the analysis, determined by the pill count back method.</offsets></p></sec><sec id="sec2dot2-nutrients-09-00116"><title><offsets xml_i="15523" xml_f="15541" txt_i="9259" txt_f="9277">2.2. Randomization</offsets></title><p><offsets xml_i="15552" xml_f="16076" txt_i="9278" txt_f="9802">Subjects were randomly allocated to the treatment or placebo group. Subjects were screened to determine eligibility, and those eligible were assigned a unique study number according to the randomisation schedule. The randomisation schedule was computer generated with blocks of variable size and stratified by BMI and gender. Randomisation was managed by an independent statistician at the Hunter Medical Research Institute. During the treatment phase, both the subjects and the investigators were blinded to the allocation.</offsets></p></sec><sec id="sec2dot3-nutrients-09-00116"><title><offsets xml_i="16131" xml_f="16152" txt_i="9804" txt_f="9825">2.3. Study Supplement</offsets></title><p><offsets xml_i="16163" xml_f="16547" txt_i="9826" txt_f="10206">The F&amp;V concentrate capsules contained a blended fruit, vegetable and berry juice powder concentrate derived from the following: acerola, cherry, apple, bilberry, blackberry, black currant, blueberry, beetroot, broccoli, cabbage, carrot, concord grape, cranberry, elderberry, kale, orange, peach, papaya, parsley, pineapple, raspberry, red currant, spinach and tomato (Juice Plus+</offsets><sup><offsets xml_i="16552" xml_f="16553" txt_i="10206" txt_f="10207">®</offsets></sup><offsets xml_i="16559" xml_f="16619" txt_i="10207" txt_f="10267"> Orchard, Garden and Berry Blends) as described previously [</offsets><xref rid="B33-nutrients-09-00116" ref-type="bibr"><offsets xml_i="16670" xml_f="16672" txt_i="10267" txt_f="10269">33</offsets></xref><offsets xml_i="16679" xml_f="16852" txt_i="10269" txt_f="10438">]. Briefly, the F&amp;V concentrate capsules provided; β-carotene 3.05 mg/day, α-tocopherol 4.8 mg/day, vitamin C 300 mg/day, folate 350 mg/day and polyphenols ~600 mg/day [</offsets><xref rid="B34-nutrients-09-00116" ref-type="bibr"><offsets xml_i="16903" xml_f="16905" txt_i="10438" txt_f="10440">34</offsets></xref><offsets xml_i="16912" xml_f="17208" txt_i="10440" txt_f="10736">]. The placebo capsules were identical in appearance, opaque white capsules containing microcrystalline cellulose. All subjects were instructed to take three capsules twice daily with meals, in agreement with the label use instructions for the retail product, for a total of six capsules per day.</offsets></p></sec><sec id="sec2dot4-nutrients-09-00116"><title><offsets xml_i="17263" xml_f="17274" txt_i="10738" txt_f="10749">2.4. Ethics</offsets></title><p><offsets xml_i="17285" xml_f="17776" txt_i="10750" txt_f="11241">The study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Hunter New England Health Human Research Ethics Committee (14/02/19/3.01) and registered with the University of Newcastle Human Research Ethics Committee. Written informed consent was obtained from all subjects. The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry (ANZCTRN12614000079640).</offsets></p></sec><sec id="sec2dot5-nutrients-09-00116"><title><offsets xml_i="17831" xml_f="17879" txt_i="11243" txt_f="11291">2.5. Anthropometric Measures and Quality of Life</offsets></title><p><offsets xml_i="17890" xml_f="18050" txt_i="11292" txt_f="11452">Anthropometric assessments (height and weight) were performed following an overnight fast. Body mass index (BMI) was calculated as body weight (kg)/(height (m))</offsets><sup><offsets xml_i="18055" xml_f="18056" txt_i="11452" txt_f="11453">2</offsets></sup><offsets xml_i="18062" xml_f="18440" txt_i="11453" txt_f="11831">. Height (metres) was measured using the stretch stature method to 2 decimal places using a wall-mounted stadiometer (Seca 220, Seca, Hamburg, Germany). Body weight (kg) was measured to 1 decimal place with subjects wearing light clothing and without shoes, using calibrated electronic scales. Quality of life was assessed by the short form health survey (SF-36) questionnaire [</offsets><xref rid="B35-nutrients-09-00116" ref-type="bibr"><offsets xml_i="18491" xml_f="18493" txt_i="11831" txt_f="11833">35</offsets></xref><offsets xml_i="18500" xml_f="18714" txt_i="11833" txt_f="12047">]. Waist circumference (WC) was measured to the nearest 0.1 cm at the midpoint between the lower costal edge and the iliac crest, using a non-extensible steel tape (Lufkin W606PM, Apex Tool Group, Sparks, MD, USA).</offsets></p></sec><sec id="sec2dot6-nutrients-09-00116"><title><offsets xml_i="18769" xml_f="18788" txt_i="12049" txt_f="12068">2.6. Blood Pressure</offsets></title><p><offsets xml_i="18799" xml_f="19276" txt_i="12069" txt_f="12546">A blood pressure cuff was placed firmly around the upper arm of the participant, centred over the brachial artery. After resting quietly in a seated position for 10 min, four consecutive blood pressure and heart rate readings were taken at one-minute intervals by a single observer using an electronic vital signs monitor (6000 Series, Welch Allyn, Skaneateles Falls, NY, USA). The first reading was discarded and an average of the remaining measurements recorded for analysis.</offsets></p></sec><sec id="sec2dot7-nutrients-09-00116"><title><offsets xml_i="19331" xml_f="19368" txt_i="12548" txt_f="12585">2.7. Dual Energy X-ray Absorptiometry</offsets></title><p><offsets xml_i="19379" xml_f="19664" txt_i="12586" txt_f="12871">Body composition was measured using a dual energy X-ray absorptiometry (DXA) machine and associated software (DXA Lunar Prodigy; Encore 2007 Version 11.40.004, GE Medical Systems, Madison, WI, USA). Total and regional absolute and percentage of fat and lean mass were calculated (kg). </offsets></p></sec><sec id="sec2dot8-nutrients-09-00116"><title><offsets xml_i="19719" xml_f="19751" txt_i="12873" txt_f="12905">2.8. Peripheral Blood Biomarkers</offsets></title><p><offsets xml_i="19762" xml_f="19867" txt_i="12906" txt_f="13011">Fasting blood was collected into ethylenediaminetetraacetic acid (EDTA) tubes, then centrifuged at 3000× </offsets><italic><offsets xml_i="19875" xml_f="19876" txt_i="13011" txt_f="13012">g</offsets></italic><offsets xml_i="19885" xml_f="20471" txt_i="13012" txt_f="13594">, at 10 °C for 10 min. Plasma was separated and stored at −80 °C for batched analysis at the end of the study. TNFα, soluble (s)TNF receptor (R) 1 and sTNFR2 were measured by Human Quantikine ELISA Kits (R&amp;D Systems, Minneapolis, Minnesota, USA). Oxidised (ox)-LDL was also analysed by ELISA (Mercodia, Uppsala, Sweden). Serum CRP, total cholesterol, LDL cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides and haemoglobin A1c (HbA1c) were measured in peripheral blood by an accredited pathology service (Hunter Area Pathology Service, Newcastle, NSW, Australia).</offsets></p></sec><sec id="sec2dot9-nutrients-09-00116"><title><offsets xml_i="20526" xml_f="20556" txt_i="13596" txt_f="13626">2.9. Plasma Antioxidant Levels</offsets></title><p><offsets xml_i="20567" xml_f="20861" txt_i="13627" txt_f="13921">Plasma carotenoids (α-carotene, β-carotene, lutein, lycopene, β-cryptoxanthin) and plasma α-tocopherol were analysed by reverse phase high-performance liquid chromatography (HPLC) (Agilent LC 1200 System, Agilent Technologies, Santa Clara, CA, USA) using methods established in our laboratory [</offsets><xref rid="B36-nutrients-09-00116" ref-type="bibr"><offsets xml_i="20912" xml_f="20914" txt_i="13921" txt_f="13923">36</offsets></xref><offsets xml_i="20921" xml_f="20922" txt_i="13923" txt_f="13924">,</offsets><xref rid="B37-nutrients-09-00116" ref-type="bibr"><offsets xml_i="20973" xml_f="20975" txt_i="13924" txt_f="13926">37</offsets></xref><offsets xml_i="20982" xml_f="20983" txt_i="13926" txt_f="13927">,</offsets><xref rid="B38-nutrients-09-00116" ref-type="bibr"><offsets xml_i="21034" xml_f="21036" txt_i="13927" txt_f="13929">38</offsets></xref><offsets xml_i="21043" xml_f="21245" txt_i="13929" txt_f="14131">]. Briefly, ethanol:ethyl acetate (1:1) containing internal standards (canthaxanthin and α-tocopherol acetate) and butylated hydroxytoluene were added to the sample. The solution was centrifuged (3000× </offsets><italic><offsets xml_i="21253" xml_f="21254" txt_i="14131" txt_f="14132">g</offsets></italic><offsets xml_i="21263" xml_f="21932" txt_i="14132" txt_f="14801">, 48 °C, 5 min), and the supernatant was collected; this was repeated 3 times adding ethyl acetate twice and then hexane to the pellet. Ultrapure water was then added to the pooled supernatant fluid, and the mixture was centrifuged. The supernatant was then decanted, and the solvents were evaporated with nitrogen. The sample was then reconstituted in dichloromethane:methanol (1:2). Chromatography was performed on a Hypersil ODS column with a flow rate of 0.3 mL/min, using the mobile phase of acetonitrile:dichloromethane:methanol 0.05% ammonium acetate (85:10:5). Carotenoids and tocopherols were detected at 450 nm and 290, respectively, using a photodiode array.</offsets></p></sec><sec id="sec2dot10-nutrients-09-00116"><title><offsets xml_i="21988" xml_f="22010" txt_i="14803" txt_f="14825">2.10. Dietary Analysis</offsets></title><p><offsets xml_i="22021" xml_f="22222" txt_i="14826" txt_f="15027">Usual dietary intake over the previous 12 months was assessed at Week 0 by food frequency questionnaire using the Dietary Questionnaire for Epidemiological Studies v2 (DQES) (Victorian Cancer Council [</offsets><xref rid="B39-nutrients-09-00116" ref-type="bibr"><offsets xml_i="22273" xml_f="22275" txt_i="15027" txt_f="15029">39</offsets></xref><offsets xml_i="22282" xml_f="22598" txt_i="15029" txt_f="15345">]). A 24-h food recall was also recorded at Week 0 and Week 8 by a dietitian and analysed using nutrient analysis software (FoodWorks Version 7, Xyris Software P/L, Kenmore Hills, QLD, Australia). Serving sizes were those as defined by the National Health and Medical Research Council Australian Dietary Guidelines [</offsets><xref rid="B40-nutrients-09-00116" ref-type="bibr"><offsets xml_i="22649" xml_f="22651" txt_i="15345" txt_f="15347">40</offsets></xref><offsets xml_i="22658" xml_f="22769" txt_i="15347" txt_f="15458">]. Briefly, 75 grams of vegetables are equivalent to one serving and 150 grams of fruit counted as one serving.</offsets></p></sec><sec id="sec2dot11-nutrients-09-00116"><title><offsets xml_i="22825" xml_f="22850" txt_i="15460" txt_f="15485">2.11. Microarray Analysis</offsets></title><p><offsets xml_i="22861" xml_f="23881" txt_i="15486" txt_f="16502">Microarray analysis was conducted in the F&amp;V concentrate group only, to detect differences in gene expression before and after the intervention. Whole blood RNA was extracted from PAXgene tubes using the PAXgene Blood RNA Extraction Kit (Qiagen, Hilden, Germany), as per the manufacturer’s instructions. RNA was quantitated and the quality assessed using Bioanalyser and Quant-iT Ribogreen RNA Reagent (Molecular Probes, Invitrogen, Carlsbad, CA, USA); the average RNA integrity number was 8.07. Whole genome gene expression was determined in 500 ng of blood RNA, which was amplified using the Illumina TotalPrep RNA Amplification Kit (Ambion, Waltham, MA, USA). Seven hundred fifty nanograms of amplified RNA were then hybridised to HumanHT-12 Version 4 Expression BeadChip (Illumina, San Diego, CA, USA). Microarrays were then scanned using the Illumina Bead Station. The microarray primary data used in this study are available at the national centre for biotechnology information (NCBI) Gene Expression Omnibus [</offsets><xref rid="B41-nutrients-09-00116" ref-type="bibr"><offsets xml_i="23932" xml_f="23934" txt_i="16502" txt_f="16504">41</offsets></xref><offsets xml_i="23941" xml_f="23976" txt_i="16504" txt_f="16539">] under Accession Number GSE87454. </offsets></p></sec><sec id="sec2dot12-nutrients-09-00116"><title><offsets xml_i="24032" xml_f="24050" txt_i="16541" txt_f="16559">2.12. PCR Analysis</offsets></title><p><offsets xml_i="24061" xml_f="24702" txt_i="16560" txt_f="17201">Real-time PCR testing was performed on 2 key genes, which demonstrated the greatest fold difference in expression and had biological relevance to the study hypothesis. Two hundred nanograms of extracted RNA (see above) were converted to cDNA using the High Capacity cDNA Reverse Transcription Hit (Applied Biosystems, Foster city, CA, USA). Standard Taqman methods were used. Taqman qPCR primer and probes of target genes were purchased in kit form (Applied Biosystems, Foster city, CA, USA). Target gene expression was measured relative to the housekeeping gene 18S, and the stability value of 18S was calculated as 0.045 using NormFinder [</offsets><xref rid="B42-nutrients-09-00116" ref-type="bibr"><offsets xml_i="24753" xml_f="24755" txt_i="17201" txt_f="17203">42</offsets></xref><offsets xml_i="24762" xml_f="25025" txt_i="17203" txt_f="17466">]. All reactions were carried out using the ABI 7500 Real-Time PCR Machine (Applied Biosystems, Foster city, CA, USA). Taqman Assay IDs are as follows; phosphomevalonate kinase (PMVK) (Hs00559915_m1) and zinc finger AN1-type containing 5 (ZFAND5) (Hs04400278_g1).</offsets></p></sec><sec id="sec2dot13-nutrients-09-00116"><title><offsets xml_i="25081" xml_f="25123" txt_i="17468" txt_f="17510">2.13. Sample Size and Statistical Analysis</offsets></title><p><offsets xml_i="25134" xml_f="25279" txt_i="17511" txt_f="17656">Sample size was determined using the Power and Sample Size calculation programme (PS Version 3.0.43, Vanderbilt University, Nashville, TN, USA) [</offsets><xref rid="B43-nutrients-09-00116" ref-type="bibr"><offsets xml_i="25330" xml_f="25332" txt_i="17656" txt_f="17658">43</offsets></xref><offsets xml_i="25339" xml_f="25455" txt_i="17658" txt_f="17774">]. Based on our previous studies of the expression of multiple genes involved in inflammatory pathways, we required </offsets><italic><offsets xml_i="25463" xml_f="25464" txt_i="17774" txt_f="17775">n</offsets></italic><offsets xml_i="25473" xml_f="25645" txt_i="17775" txt_f="17947"> = 26 subjects per group to have 80% power to detect a mean difference in expression of genes of 20%, with standard deviation (SD) = 25%. Our initial recruitment target of </offsets><italic><offsets xml_i="25653" xml_f="25654" txt_i="17947" txt_f="17948">n</offsets></italic><offsets xml_i="25663" xml_f="25730" txt_i="17948" txt_f="18015"> = 64 allowed for 20% dropouts; however, recruitment was ceased at </offsets><italic><offsets xml_i="25738" xml_f="25739" txt_i="18015" txt_f="18016">n</offsets></italic><offsets xml_i="25748" xml_f="25801" txt_i="18016" txt_f="18069"> = 61, as a very low dropout rate of 8% was achieved.</offsets></p><p><offsets xml_i="25808" xml_f="26164" txt_i="18070" txt_f="18426">Per protocol analysis was conducted in 2 stages; Part 1: analysis of the full cohort; Part 2: analysis of the subset of individuals who are at increased risk of chronic disease due to high systemic inflammation levels at baseline, defined as serum CRP ≥3.0 mg/mL. The normality of all data was assessed using the D’Agostino–Pearson omnibus normality test. </offsets></p><p><offsets xml_i="26171" xml_f="26273" txt_i="18427" txt_f="18529">Baseline data: demographics, biomarkers and dietary intake were compared using the unpaired Student’s </offsets><italic><offsets xml_i="26281" xml_f="26282" txt_i="18529" txt_f="18530">t</offsets></italic><offsets xml_i="26291" xml_f="26361" txt_i="18530" txt_f="18600">-test (parametric data) or Mann–Whitney U-test (non-parametric data). </offsets></p><p><offsets xml_i="26368" xml_f="26470" txt_i="18601" txt_f="18703">Intervention results: following the intervention, within-group differences were compared using paired </offsets><italic><offsets xml_i="26478" xml_f="26479" txt_i="18703" txt_f="18704">t</offsets></italic><offsets xml_i="26488" xml_f="26910" txt_i="18704" txt_f="19126">-tests for parametric data or the Wilcoxon rank sum test for non-parametric data. Between-group differences were analysed using analysis of covariance (ANCOVA) to test for differences between treatment groups after adjusting for baseline values. Associations between variables were assessed using Pearson’s correlation for normally distributed variables and Spearman’s rank correlation coefficient for non-parametric data.</offsets></p><p><offsets xml_i="26917" xml_f="27145" txt_i="19127" txt_f="19355">Microarray whole genome gene expression analysis: data were exported to RStudio Version 3.2.2 (RStudio, Boston, MA, USA) using Illumina’s Genome Studio 3.0 (Illumina, San Diego, CA, USA) and processed using the R packages lumi [</offsets><xref rid="B44-nutrients-09-00116" ref-type="bibr"><offsets xml_i="27196" xml_f="27198" txt_i="19355" txt_f="19357">44</offsets></xref><offsets xml_i="27205" xml_f="27218" txt_i="19357" txt_f="19370">] and limma [</offsets><xref rid="B45-nutrients-09-00116" ref-type="bibr"><offsets xml_i="27269" xml_f="27271" txt_i="19370" txt_f="19372">45</offsets></xref><offsets xml_i="27278" xml_f="27608" txt_i="19372" txt_f="19702">]. Data were normalised via log transformation and the baseline converted to the median of all samples. Data were filtered based on whether the gene was detected as present in 28 or more samples, as this was half the samples available from the intervention group. Gene profiles were analysed for differential expression by paired </offsets><italic><offsets xml_i="27616" xml_f="27617" txt_i="19702" txt_f="19703">t</offsets></italic><offsets xml_i="27626" xml_f="27691" txt_i="19703" txt_f="19768">-test for significance and fold change in RStudio Version 3.2.2. </offsets></p></sec></sec><sec id="sec3-nutrients-09-00116"><title><offsets xml_i="27748" xml_f="27758" txt_i="19771" txt_f="19781">3. Results</offsets></title><sec id="sec3dot1-nutrients-09-00116"><title><offsets xml_i="27811" xml_f="27847" txt_i="19782" txt_f="19818">3.1. Part 1: Analysis of Full Cohort</offsets></title><sec id="sec3dot1dot1-nutrients-09-00116"><title><offsets xml_i="27904" xml_f="27927" txt_i="19819" txt_f="19842">3.1.1. Participant Flow</offsets></title><p><offsets xml_i="27938" xml_f="28011" txt_i="19843" txt_f="19916">Sixty-one subjects were randomised, with five withdrawing after visit 1 (</offsets><xref ref-type="fig" rid="nutrients-09-00116-f001"><offsets xml_i="28062" xml_f="28070" txt_i="19916" txt_f="19924">Figure 1</offsets></xref><offsets xml_i="28077" xml_f="28535" txt_i="19924" txt_f="20378">). Of those who withdrew, one was suffering from constipation and fluid retention, one was suffering from diarrhoea and stomach pain, one had difficulty swallowing the study medication, one required anti-inflammatory treatment for a prior knee injury and one no longer wished to participate in the study. Of the 56 subjects who completed the study, 28 were in the F&amp;V concentrate group and 28 were in the placebo group. The mean adherence rate was 97.7%.</offsets></p></sec><sec id="sec3dot1dot2-nutrients-09-00116"><title><offsets xml_i="28594" xml_f="28664" txt_i="20380" txt_f="20450">3.1.2. Subject Demographics, Dietary Intake and Plasma Nutrient Levels</offsets></title><p><offsets xml_i="28675" xml_f="28766" txt_i="20451" txt_f="20542">At baseline, there were no differences between groups in demographics or nutrient intakes (</offsets><xref ref-type="table" rid="nutrients-09-00116-t001"><offsets xml_i="28819" xml_f="28826" txt_i="20542" txt_f="20549">Table 1</offsets></xref><offsets xml_i="28833" xml_f="28970" txt_i="20549" txt_f="20686">). Daily intake of fruit and vegetables was also not different at baseline between the groups and was well below the recommended levels (</offsets><xref ref-type="table" rid="nutrients-09-00116-t002"><offsets xml_i="29023" xml_f="29030" txt_i="20686" txt_f="20693">Table 2</offsets></xref><offsets xml_i="29037" xml_f="29107" txt_i="20693" txt_f="20763">). Fruit and vegetable intake did not change during the intervention (</offsets><xref ref-type="table" rid="nutrients-09-00116-t002"><offsets xml_i="29160" xml_f="29167" txt_i="20763" txt_f="20770">Table 2</offsets></xref><offsets xml_i="29174" xml_f="29332" txt_i="20770" txt_f="20924">). After eight weeks, plasma β-carotene and total carotenoids increased significantly within the F&amp;V concentrate group and compared to the placebo group (</offsets><xref ref-type="table" rid="nutrients-09-00116-t002"><offsets xml_i="29385" xml_f="29392" txt_i="20924" txt_f="20931">Table 2</offsets></xref><offsets xml_i="29399" xml_f="29498" txt_i="20931" txt_f="21026">). Plasma lycopene levels decreased in the placebo group compared to the F&amp;V concentrate group.</offsets></p></sec><sec id="sec3dot1dot3-nutrients-09-00116"><title><offsets xml_i="29557" xml_f="29633" txt_i="21028" txt_f="21104">3.1.3. Lipid Profile, Glycated Haemoglobin and Systemic Inflammatory Markers</offsets></title><p><offsets xml_i="29644" xml_f="30049" txt_i="21105" txt_f="21498">Total cholesterol and LDL cholesterol decreased within the F&amp;V concentrate group only, while triglycerides increased in the placebo group. Comparison of the two groups showed that only the change (Δ) in triglycerides was different between the F&amp;V concentrate and placebo groups. Glycated haemoglobin (HbA1c) was unchanged after the intervention in both the F&amp;V concentrate and placebo groups (</offsets><xref ref-type="table" rid="nutrients-09-00116-t003"><offsets xml_i="30102" xml_f="30109" txt_i="21498" txt_f="21505">Table 3</offsets></xref><offsets xml_i="30116" xml_f="30296" txt_i="21505" txt_f="21677">). Plasma TNFα decreased following the F&amp;V concentrate supplementation, and the difference in ΔTNFα between the F&amp;V concentrate and placebo groups approached significance (</offsets><italic><offsets xml_i="30304" xml_f="30305" txt_i="21677" txt_f="21678">p</offsets></italic><offsets xml_i="30314" xml_f="30389" txt_i="21678" txt_f="21753"> = 0.071). There was a negative correlation between Δβ-carotene and ΔTNFα (</offsets><italic><offsets xml_i="30397" xml_f="30398" txt_i="21753" txt_f="21754">r</offsets></italic><offsets xml_i="30407" xml_f="30418" txt_i="21754" txt_f="21765"> = −0.352, </offsets><italic><offsets xml_i="30426" xml_f="30427" txt_i="21765" txt_f="21766">p</offsets></italic><offsets xml_i="30436" xml_f="30615" txt_i="21766" txt_f="21941"> = 0.018). Plasma sTNFR2 concentration increased in the placebo group, while plasma sTNFR1, ox-LDL and CRP were unchanged in the F&amp;V concentrate and placebo groups at Week 8 (</offsets><xref ref-type="table" rid="nutrients-09-00116-t003"><offsets xml_i="30668" xml_f="30675" txt_i="21941" txt_f="21948">Table 3</offsets></xref><offsets xml_i="30682" xml_f="30684" txt_i="21948" txt_f="21950">).</offsets></p></sec><sec id="sec3dot1dot4-nutrients-09-00116"><title><offsets xml_i="30743" xml_f="30837" txt_i="21952" txt_f="22046">3.1.4. Body Composition, Blood Pressure and Quality of Life before and after the Intervention </offsets></title><p><offsets xml_i="30848" xml_f="30951" txt_i="22047" txt_f="22146">Weight, BMI and waist circumference did not change in both the F&amp;V concentrate and placebo groups (</offsets><xref ref-type="table" rid="nutrients-09-00116-t004"><offsets xml_i="31004" xml_f="31011" txt_i="22146" txt_f="22153">Table 4</offsets></xref><offsets xml_i="31018" xml_f="31155" txt_i="22153" txt_f="22286">). Total lean mass increased within the F&amp;V concentrate group, and the change compared to the placebo group approached significance (</offsets><italic><offsets xml_i="31163" xml_f="31164" txt_i="22286" txt_f="22287">p</offsets></italic><offsets xml_i="31173" xml_f="31504" txt_i="22287" txt_f="22610"> = 0.057). Systolic blood pressure was significantly decreased after eight weeks in both the F&amp;V concentrate and placebo groups; however, the difference between groups was not significant. Diastolic blood pressure, pulse and quality of life (SF36) were not changed after the F&amp;V concentrate supplementation or the placebo (</offsets><xref ref-type="table" rid="nutrients-09-00116-t004"><offsets xml_i="31557" xml_f="31564" txt_i="22610" txt_f="22617">Table 4</offsets></xref><offsets xml_i="31571" xml_f="31573" txt_i="22617" txt_f="22619">).</offsets></p></sec></sec><sec id="sec3dot2-nutrients-09-00116"><title><offsets xml_i="31634" xml_f="31705" txt_i="22622" txt_f="22693">3.2. Part 2: Analysis of a Subgroup with High Baseline CRP (≥3.0 mg/mL)</offsets></title><sec id="sec3dot2dot1-nutrients-09-00116"><title><offsets xml_i="31762" xml_f="31832" txt_i="22694" txt_f="22764">3.2.1. Subject Demographics, Dietary Intake and Plasma Nutrient Levels</offsets></title><p><italic><offsets xml_i="31851" xml_f="31852" txt_i="22765" txt_f="22766">n</offsets></italic><offsets xml_i="31861" xml_f="31871" txt_i="22766" txt_f="22776"> = 17 and </offsets><italic><offsets xml_i="31879" xml_f="31880" txt_i="22776" txt_f="22777">n</offsets></italic><offsets xml_i="31889" xml_f="31987" txt_i="22777" txt_f="22875"> = 15, respectively. The baseline demographics and dietary intakes of these groups were analysed (</offsets><xref ref-type="table" rid="nutrients-09-00116-t005"><offsets xml_i="32040" xml_f="32047" txt_i="22875" txt_f="22882">Table 5</offsets></xref><offsets xml_i="32054" xml_f="32325" txt_i="22882" txt_f="23153">) and found to be similar, except for BMI, which was higher in the placebo group. Baseline daily intake of fruit and vegetables was not different between the groups and was well below recommended levels. Fruit and vegetable intake did not change during the intervention (</offsets><xref ref-type="table" rid="nutrients-09-00116-t006"><offsets xml_i="32378" xml_f="32385" txt_i="23153" txt_f="23160">Table 6</offsets></xref><offsets xml_i="32392" xml_f="32638" txt_i="23160" txt_f="23398">). Plasma β-carotene and total carotenoids were both increased within the F&amp;V concentrate group compared to the placebo group at Week 8. Lycopene was significantly decreased within the placebo group compared to the F&amp;V concentrate group (</offsets><xref ref-type="table" rid="nutrients-09-00116-t006"><offsets xml_i="32691" xml_f="32698" txt_i="23398" txt_f="23405">Table 6</offsets></xref><offsets xml_i="32705" xml_f="32707" txt_i="23405" txt_f="23407">).</offsets></p></sec><sec id="sec3dot2dot2-nutrients-09-00116"><title><offsets xml_i="32766" xml_f="32841" txt_i="23409" txt_f="23484">3.2.2. Blood Lipids, Glycated Haemoglobin and Systemic Inflammatory Markers</offsets></title><p><offsets xml_i="32852" xml_f="33005" txt_i="23485" txt_f="23634">Cholesterol and LDL cholesterol were significantly decreased within the F&amp;V concentrate group, but were not different compared to the placebo group (</offsets><xref ref-type="table" rid="nutrients-09-00116-t007"><offsets xml_i="33058" xml_f="33065" txt_i="23634" txt_f="23641">Table 7</offsets></xref><offsets xml_i="33072" xml_f="33345" txt_i="23641" txt_f="23906">). Triglycerides, HDL cholesterol, total cholesterol/HDL ratio and HbA1c were unchanged within either the F&amp;V concentrate or placebo groups. Plasma levels of TNFα were significantly decreased within the F&amp;V concentrate group and also compared to the placebo group (</offsets><xref ref-type="table" rid="nutrients-09-00116-t007"><offsets xml_i="33398" xml_f="33405" txt_i="23906" txt_f="23913">Table 7</offsets></xref><offsets xml_i="33412" xml_f="33639" txt_i="23913" txt_f="24140">). The soluble receptors, sTNFR1 and sTNFR2, were significantly different between groups following the intervention, due to an increase in concentration in the placebo group. Oxidised-LDL and CRP were unchanged in both groups (</offsets><xref ref-type="table" rid="nutrients-09-00116-t007"><offsets xml_i="33692" xml_f="33699" txt_i="24140" txt_f="24147">Table 7</offsets></xref><offsets xml_i="33706" xml_f="33708" txt_i="24147" txt_f="24149">).</offsets></p></sec><sec id="sec3dot2dot3-nutrients-09-00116"><title><offsets xml_i="33767" xml_f="33861" txt_i="24151" txt_f="24245">3.2.3. Body Composition, Blood Pressure and Quality of Life Before and after the Intervention </offsets></title><p><offsets xml_i="33872" xml_f="34004" txt_i="24246" txt_f="24378">At the completion of the trial, weight, BMI, waist circumference, blood pressure and quality of life were unchanged in both groups (</offsets><xref ref-type="table" rid="nutrients-09-00116-t008"><offsets xml_i="34057" xml_f="34064" txt_i="24378" txt_f="24385">Table 8</offsets></xref><offsets xml_i="34071" xml_f="34220" txt_i="24385" txt_f="24530">). Total lean mass and pulse rate significantly increased within the F&amp;V concentrate group, but were not different compared to the placebo group.</offsets></p></sec><sec id="sec3dot2dot4-nutrients-09-00116"><title><offsets xml_i="34279" xml_f="34318" txt_i="24532" txt_f="24571">3.2.4. Peripheral Blood Gene Expression</offsets></title><p><offsets xml_i="34329" xml_f="34385" txt_i="24572" txt_f="24628">In the subgroup of participants with high baseline CRP (</offsets><italic><offsets xml_i="34393" xml_f="34394" txt_i="24628" txt_f="24629">n</offsets></italic><offsets xml_i="34403" xml_f="34721" txt_i="24629" txt_f="24943"> = 16), microarray analysis revealed that 1632 genes were differentially expressed after supplementation with the F&amp;V concentrate. One thousand one hundred forty six genes were upregulated, while 486 genes were downregulated, with the highest absolute fold change being 1.44 and the lowest fold change being 1.03. </offsets></p><p><offsets xml_i="34728" xml_f="34936" txt_i="24944" txt_f="25152">From the genes that were significantly differentially expressed, several genes were identified that are involved in biologically-relevant signalling pathways, including: lipogenesis, NF-kB and AMPK pathways (</offsets><xref ref-type="table" rid="nutrients-09-00116-t009"><offsets xml_i="34989" xml_f="34996" txt_i="25152" txt_f="25159">Table 9</offsets></xref><offsets xml_i="35003" xml_f="35094" txt_i="25159" txt_f="25250">). Pathways analysis was also performed on genes that were differentially expressed with a </offsets><italic><offsets xml_i="35102" xml_f="35103" txt_i="25250" txt_f="25251">p</offsets></italic><offsets xml_i="35112" xml_f="35189" txt_i="25251" txt_f="25325"> &lt; 0.05, using gene ontology tool to help explain relationships (GATHER) [</offsets><xref rid="B46-nutrients-09-00116" ref-type="bibr"><offsets xml_i="35240" xml_f="35242" txt_i="25325" txt_f="25327">46</offsets></xref><offsets xml_i="35249" xml_f="36496" txt_i="25327" txt_f="26574">]. The upregulated genes were found to be involved in five different pathways, those being: the insulin signalling pathway, neuroactive ligand-receptor interaction, adherens junction, regulation of the actin cytoskeleton and the wnt signalling pathway. There were 18 upregulated genes involved in the insulin signalling pathway: calmodulin 1 (CALM1), casitas B-lineage lymphoma (CBL), crk-like protein (CRKL), hexokinase 2 (HK2), insulin receptor substrate 2 (IRS2), mitogen-activated protein kinase kinase 1 (MAP2K1), mitogen-activated protein kinase 6 (MAPK6), phosphodiesterase 3B (PDE3B), phosphorylase kinase regulatory subunit beta (PHKB), phosphatidylinositol-4, 5-biphosphate 3-kinase catalytic subunit beta isoform (PIK3CB), protein phosphatase 1 catalytic subunit gamma (PPP1CC), 5′-AMP-activated protein kinase subunit gamma-2 (PRKAG2), cAMP-dependent protein kinase type I-alpha regulatory subunit (PRKAR1A), tyrosine-protein phosphatase non-receptor type 1 (PTPN1), glycogen phosphorylase, liver form (PYGL), raf-1 proto-oncogene, serine/threonine kinase (RAF1), ras homolog enriched in brain (RHEB), ras-related protein R-Ras2 (RRAS2). Two gene targets for qPCR analysis were chosen to validate the microarray data; ZFAND5 and PMVK. </offsets><xref ref-type="fig" rid="nutrients-09-00116-f002"><offsets xml_i="36547" xml_f="36555" txt_i="26574" txt_f="26582">Figure 2</offsets></xref><offsets xml_i="36562" xml_f="37039" txt_i="26582" txt_f="27055"> shows that ZFAND5 and PMVK mRNA expression had similar fold changes following the intervention when assessed using both microarray and qPCR. As seen in the microarray analysis, gene expression of ZFAND5 as determined by PCR analysis was also significantly upregulated following supplementation with the F&amp;V concentrate. While PMVK expression was downregulated in the microarray analysis, the downregulated expression in the PCR analysis was not statistically significant (</offsets><xref ref-type="fig" rid="nutrients-09-00116-f003"><offsets xml_i="37090" xml_f="37098" txt_i="27055" txt_f="27063">Figure 3</offsets></xref><offsets xml_i="37105" xml_f="37107" txt_i="27063" txt_f="27065">).</offsets></p></sec></sec></sec><sec id="sec4-nutrients-09-00116"><title><offsets xml_i="37170" xml_f="37183" txt_i="27069" txt_f="27082">4. Discussion</offsets></title><p><offsets xml_i="37194" xml_f="38169" txt_i="27083" txt_f="28050">In this study, we found that in older subjects who are overweight or obese, F&amp;V concentrate supplementation led to decreases in total cholesterol, LDL cholesterol, TNFα and systolic blood pressure. We conducted a secondary analysis of the subgroup of participants who had high systemic inflammation at baseline, as we hypothesised that these participants were more likely to obtain an improvement in metabolic health as a result of the supplement. Similar results were observed in the subgroup analysis, with F&amp;V concentrate supplementation leading to a decrease in total cholesterol, LDL cholesterol and TNFα, and indeed, the size of the effects was greater. A number of genes associated with lipogenesis, AMPK and NF-κB signalling pathways were differentially expressed following the intervention. Pathways analysis also revealed that several genes involved in the insulin signalling pathway were upregulated in the subgroup of participants with high baseline CRP. </offsets></p><p><offsets xml_i="38176" xml_f="38494" txt_i="28051" txt_f="28365">Total and LDL cholesterol were both found to be significantly decreased after the F&amp;V concentrate intervention with greater changes seen in the subgroup with high baseline CRP. A recent Cochrane review used meta-analyses to demonstrate that increased fruit and vegetable consumption can reduce cholesterol levels [</offsets><xref rid="B47-nutrients-09-00116" ref-type="bibr"><offsets xml_i="38545" xml_f="38547" txt_i="28365" txt_f="28367">47</offsets></xref><offsets xml_i="38554" xml_f="39229" txt_i="28367" txt_f="29042">]. Included studies achieved an average increase in fruit and vegetable intake of 1.88 (95% confidence interval (CI): 1.07 to 2.70) servings per day and total blood cholesterol levels reduced by 0.11 mmol/L (95% CI: −0.19 to −0.03). We observed a much greater decrease in total cholesterol in the high baseline CRP subgroup in this study. Importantly, the size of the decreases in total and LDL cholesterol that were observed in this study are substantial and clinically important. In the full cohort analysis, we observed a 0.2 mmol/L (3.5%) reduction in total cholesterol, which is estimated to be equivalent to a weight loss of 4 kg and an 8% to 9% reduction in CVD risk [</offsets><xref rid="B48-nutrients-09-00116" ref-type="bibr"><offsets xml_i="39280" xml_f="39282" txt_i="29042" txt_f="29044">48</offsets></xref><offsets xml_i="39289" xml_f="39290" txt_i="29044" txt_f="29045">,</offsets><xref rid="B49-nutrients-09-00116" ref-type="bibr"><offsets xml_i="39341" xml_f="39343" txt_i="29045" txt_f="29047">49</offsets></xref><offsets xml_i="39350" xml_f="39501" txt_i="29047" txt_f="29198">]. We also observed a 0.13 mmol/L (3.5%) decrease in LDL cholesterol, estimated to be equivalent to a 6.5 kg weight loss and 5% reduction in CVD risk [</offsets><xref rid="B48-nutrients-09-00116" ref-type="bibr"><offsets xml_i="39552" xml_f="39554" txt_i="29198" txt_f="29200">48</offsets></xref><offsets xml_i="39561" xml_f="39562" txt_i="29200" txt_f="29201">,</offsets><xref rid="B49-nutrients-09-00116" ref-type="bibr"><offsets xml_i="39613" xml_f="39615" txt_i="29201" txt_f="29203">49</offsets></xref><offsets xml_i="39622" xml_f="39856" txt_i="29203" txt_f="29437">]. In subjects who had elevated systemic inflammation at baseline, we observed a 0.45 mmol/L (7.4%) reduction in total cholesterol, which is estimated to be equivalent to a weight loss of 9 kg and an 18% to 19% reduction in CVD risk [</offsets><xref rid="B48-nutrients-09-00116" ref-type="bibr"><offsets xml_i="39907" xml_f="39909" txt_i="29437" txt_f="29439">48</offsets></xref><offsets xml_i="39916" xml_f="39917" txt_i="29439" txt_f="29440">,</offsets><xref rid="B49-nutrients-09-00116" ref-type="bibr"><offsets xml_i="39968" xml_f="39970" txt_i="29440" txt_f="29442">49</offsets></xref><offsets xml_i="39977" xml_f="40144" txt_i="29442" txt_f="29609">]. In this group, we also observed a 0.16 mmol/L (4.0%) decrease in LDL cholesterol, estimated to be equivalent to an 8 kg weight loss and a 4% reduction in CVD risk [</offsets><xref rid="B48-nutrients-09-00116" ref-type="bibr"><offsets xml_i="40195" xml_f="40197" txt_i="29609" txt_f="29611">48</offsets></xref><offsets xml_i="40204" xml_f="40205" txt_i="29611" txt_f="29612">,</offsets><xref rid="B49-nutrients-09-00116" ref-type="bibr"><offsets xml_i="40256" xml_f="40258" txt_i="29612" txt_f="29614">49</offsets></xref><offsets xml_i="40265" xml_f="40267" txt_i="29614" txt_f="29616">].</offsets></p><p><offsets xml_i="40274" xml_f="40694" txt_i="29617" txt_f="30029">Serum triglycerides were found to be unchanged by the F&amp;V concentrate in both the full cohort analysis and the high baseline CRP subgroup analysis. However, we did observe an inverse correlation between Δβ-carotene and Δtriglycerides. There is previous evidence that F&amp;V concentrate supplementation and polyphenol-rich diets can lower triglyceride levels in overweight boys with elevated baseline triglycerides [</offsets><xref rid="B50-nutrients-09-00116" ref-type="bibr"><offsets xml_i="40745" xml_f="40747" txt_i="30029" txt_f="30031">50</offsets></xref><offsets xml_i="40754" xml_f="40791" txt_i="30031" txt_f="30068">] and in overweight or obese adults [</offsets><xref rid="B51-nutrients-09-00116" ref-type="bibr"><offsets xml_i="40842" xml_f="40844" txt_i="30068" txt_f="30070">51</offsets></xref><offsets xml_i="40851" xml_f="41624" txt_i="30070" txt_f="30835">]. It is likely that F&amp;V concentrate supplementation would have the greatest effect in individuals with elevated triglycerides, which may explain the lack of change in this study, as the majority of subjects had normal triglyceride levels at baseline. Interestingly, in the placebo group, triglycerides significantly increased in the full cohort analysis after the intervention. This may be related to the decrease in total carotenoids that was observed in the placebo group after eight weeks, which indicates that bioactive compounds continued to washout during the intervention period. This may have also masked the effect of the F&amp;V concentrate, if dietary sources of carotenoids and other phytochemicals were continuing to washout during the intervention phase.</offsets></p><p><offsets xml_i="41631" xml_f="41780" txt_i="30836" txt_f="30981">Microarray analysis revealed differential expression of several key genes involved in lipogenesis following the F&amp;V concentrate supplementation. </offsets><italic><offsets xml_i="41788" xml_f="41792" txt_i="30981" txt_f="30985">PMVK</offsets></italic><offsets xml_i="41801" xml_f="41877" txt_i="30985" txt_f="31061"> (or phosphomevalonate kinase) was found to be significantly downregulated. </offsets><italic><offsets xml_i="41885" xml_f="41889" txt_i="31061" txt_f="31065">PMVK</offsets></italic><offsets xml_i="41898" xml_f="42046" txt_i="31065" txt_f="31213"> catalyses conversion of mevalonate 5-phosphate into mevalonate 5-diphosphate, which is the fifth reaction of the cholesterol biosynthetic pathway [</offsets><xref rid="B52-nutrients-09-00116" ref-type="bibr"><offsets xml_i="42097" xml_f="42099" txt_i="31213" txt_f="31215">52</offsets></xref><offsets xml_i="42106" xml_f="42170" txt_i="31215" txt_f="31279">]. Similarly, gene expression of farnesyl diphosphate synthase (</offsets><italic><offsets xml_i="42178" xml_f="42182" txt_i="31279" txt_f="31283">FDPS</offsets></italic><offsets xml_i="42191" xml_f="42350" txt_i="31283" txt_f="31442">) was downregulated. This may also lead to reduced cholesterol production as the gene encodes an enzyme that catalyses the production of farnesyl diphosphate (</offsets><italic><offsets xml_i="42358" xml_f="42361" txt_i="31442" txt_f="31445">FPP</offsets></italic><offsets xml_i="42370" xml_f="42443" txt_i="31445" txt_f="31518">), a key biosynthetic intermediate used in the formation of cholesterol [</offsets><xref rid="B53-nutrients-09-00116" ref-type="bibr"><offsets xml_i="42494" xml_f="42496" txt_i="31518" txt_f="31520">53</offsets></xref><offsets xml_i="42503" xml_f="42795" txt_i="31520" txt_f="31808">]. Interestingly, a recent study has shown that supplementation with the same F&amp;V concentrate used in this study led to increased levels of circulating fatty acid binding protein 4 (FABP4), possibly via modulation of PPAR activity, resulting in altered lipid metabolism and accumulation [</offsets><xref rid="B54-nutrients-09-00116" ref-type="bibr"><offsets xml_i="42846" xml_f="42848" txt_i="31808" txt_f="31810">54</offsets></xref><offsets xml_i="42855" xml_f="43007" txt_i="31810" txt_f="31958">]. Hence, there are several mechanisms by which the F&amp;V concentrate may have led to the reduced blood lipid levels that were observed in this study.</offsets></p><p><offsets xml_i="43014" xml_f="43493" txt_i="31959" txt_f="32434">Following intervention with the F&amp;V concentrate, there was a small, but statistically-significant reduction in TNFα in the full cohort analysis, with a much greater reduction seen in the high baseline CRP subgroup analysis. TNFα is a cell signalling protein involved in systemic inflammation, with a primary role of regulating immune cells. Previous studies have shown that increasing fruit and vegetable intake reduces systemic inflammation, specifically CRP concentration [</offsets><xref rid="B55-nutrients-09-00116" ref-type="bibr"><offsets xml_i="43544" xml_f="43546" txt_i="32434" txt_f="32436">55</offsets></xref><offsets xml_i="43553" xml_f="43554" txt_i="32436" txt_f="32437">,</offsets><xref rid="B56-nutrients-09-00116" ref-type="bibr"><offsets xml_i="43605" xml_f="43607" txt_i="32437" txt_f="32439">56</offsets></xref><offsets xml_i="43614" xml_f="43864" txt_i="32439" txt_f="32685">], while a previous study of F&amp;V concentrate supplementation showed that monocyte chemotactic protein 1 (MCP-1), macrophage inflammatory protein 1b (MIP-1b) and regulated on activation, normal T cell expressed and secreted (RANTES) were reduced [</offsets><xref rid="B57-nutrients-09-00116" ref-type="bibr"><offsets xml_i="43915" xml_f="43917" txt_i="32685" txt_f="32687">57</offsets></xref><offsets xml_i="43924" xml_f="44074" txt_i="32687" txt_f="32833">]. The F&amp;V concentrate used in this study is rich in β-carotene, which has been shown to reduce inflammatory mediator production, including TNFα [</offsets><xref rid="B58-nutrients-09-00116" ref-type="bibr"><offsets xml_i="44125" xml_f="44127" txt_i="32833" txt_f="32835">58</offsets></xref><offsets xml_i="44134" xml_f="44135" txt_i="32835" txt_f="32836">,</offsets><xref rid="B59-nutrients-09-00116" ref-type="bibr"><offsets xml_i="44186" xml_f="44188" txt_i="32836" txt_f="32838">59</offsets></xref><offsets xml_i="44195" xml_f="44318" txt_i="32838" txt_f="32961">]. For example, a study in mice found that β-carotene reduced the inflammatory response to LPS, including TNFα production [</offsets><xref rid="B59-nutrients-09-00116" ref-type="bibr"><offsets xml_i="44369" xml_f="44371" txt_i="32961" txt_f="32963">59</offsets></xref><offsets xml_i="44378" xml_f="44528" txt_i="32963" txt_f="33113">]. Another study in a non-alcoholic fatty liver model in rats found that TNFα levels were markedly ameliorated with the administration of β-carotene [</offsets><xref rid="B58-nutrients-09-00116" ref-type="bibr"><offsets xml_i="44579" xml_f="44581" txt_i="33113" txt_f="33115">58</offsets></xref><offsets xml_i="44588" xml_f="44684" txt_i="33115" txt_f="33211">]. Hence, the potential for carotenoids to reduce inflammation has previously been demonstrated.</offsets></p><p><offsets xml_i="44691" xml_f="45259" txt_i="33212" txt_f="33780">TNFR1 and TNFR2 are the receptors to TNFα. Upon binding, inflammation is induced via various pathways, including activation of NF-kB and MAPK pathways. In this study, TNFR2 increased in the placebo group, in both the full cohort analysis and the subgroup analysis. Again, we speculate that this may have been a result of the decrease in total carotenoids that occurred in the placebo group during the intervention period, which suggests that the two-week washout period was not long enough to washout background levels of carotenoids prior to the intervention period. </offsets></p><p><offsets xml_i="45266" xml_f="45779" txt_i="33781" txt_f="34290">A number of key genes involved in adenosine monophosphate-activated protein kinase (AMPK) and NF-κB signalling were found to be differentially expressed following intervention with F&amp;V concentrate, and these may have contributed to the anti-inflammatory effect that we observed. AMPK is a key regulator of energy metabolism homeostasis, as AMPK inhibits energy consuming activities, such as protein, fatty acid and cholesterol synthesis, and stimulates energy production through glucose and lipid catabolism [</offsets><xref rid="B60-nutrients-09-00116" ref-type="bibr"><offsets xml_i="45830" xml_f="45832" txt_i="34290" txt_f="34292">60</offsets></xref><offsets xml_i="45839" xml_f="45921" txt_i="34292" txt_f="34374">]. AMPK activation can also inhibit NF-κB signalling, thus reducing inflammation [</offsets><xref rid="B60-nutrients-09-00116" ref-type="bibr"><offsets xml_i="45972" xml_f="45974" txt_i="34374" txt_f="34376">60</offsets></xref><offsets xml_i="45981" xml_f="46057" txt_i="34376" txt_f="34452">], and impaired AMPK activity has been shown to lead to insulin resistance [</offsets><xref rid="B61-nutrients-09-00116" ref-type="bibr"><offsets xml_i="46108" xml_f="46110" txt_i="34452" txt_f="34454">61</offsets></xref><offsets xml_i="46117" xml_f="46118" txt_i="34454" txt_f="34455">,</offsets><xref rid="B62-nutrients-09-00116" ref-type="bibr"><offsets xml_i="46169" xml_f="46171" txt_i="34455" txt_f="34457">62</offsets></xref><offsets xml_i="46178" xml_f="46323" txt_i="34457" txt_f="34598">]. AMPK signalling genes that were upregulated following the F&amp;V concentrate intervention that have known anti-inflammatory effects include: </offsets><italic><offsets xml_i="46331" xml_f="46335" txt_i="34598" txt_f="34602">IRS2</offsets></italic><offsets xml_i="46344" xml_f="46346" txt_i="34602" txt_f="34604">, </offsets><italic><offsets xml_i="46354" xml_f="46359" txt_i="34604" txt_f="34609">CAB39</offsets></italic><offsets xml_i="46368" xml_f="46373" txt_i="34609" txt_f="34614"> and </offsets><italic><offsets xml_i="46381" xml_f="46386" txt_i="34614" txt_f="34619">SIRT1</offsets></italic><offsets xml_i="46395" xml_f="46441" txt_i="34619" txt_f="34665">. Previously, a study found that knockdown of </offsets><italic><offsets xml_i="46449" xml_f="46453" txt_i="34665" txt_f="34669">IRS2</offsets></italic><offsets xml_i="46462" xml_f="46552" txt_i="34669" txt_f="34759"> expression resulted in mice developing insulin resistance due to increased inflammation [</offsets><xref rid="B63-nutrients-09-00116" ref-type="bibr"><offsets xml_i="46603" xml_f="46605" txt_i="34759" txt_f="34761">63</offsets></xref><offsets xml_i="46612" xml_f="46683" txt_i="34761" txt_f="34832">], while another study in mice found that AMPK signalling activated by </offsets><italic><offsets xml_i="46691" xml_f="46696" txt_i="34832" txt_f="34837">CAB39</offsets></italic><offsets xml_i="46705" xml_f="46733" txt_i="34837" txt_f="34865"> inhibits NF-κB activation [</offsets><xref rid="B64-nutrients-09-00116" ref-type="bibr"><offsets xml_i="46784" xml_f="46786" txt_i="34865" txt_f="34867">64</offsets></xref><offsets xml_i="46793" xml_f="46887" txt_i="34867" txt_f="34961">]. SIRT1, a downstream target of AMPK, inhibits NF-κB signalling, thus reducing inflammation [</offsets><xref rid="B60-nutrients-09-00116" ref-type="bibr"><offsets xml_i="46938" xml_f="46940" txt_i="34961" txt_f="34963">60</offsets></xref><offsets xml_i="46947" xml_f="46948" txt_i="34963" txt_f="34964">,</offsets><xref rid="B65-nutrients-09-00116" ref-type="bibr"><offsets xml_i="46999" xml_f="47001" txt_i="34964" txt_f="34966">65</offsets></xref><offsets xml_i="47008" xml_f="47009" txt_i="34966" txt_f="34967">,</offsets><xref rid="B66-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47060" xml_f="47062" txt_i="34967" txt_f="34969">66</offsets></xref><offsets xml_i="47069" xml_f="47070" txt_i="34969" txt_f="34970">,</offsets><xref rid="B67-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47121" xml_f="47123" txt_i="34970" txt_f="34972">67</offsets></xref><offsets xml_i="47130" xml_f="47191" txt_i="34972" txt_f="35033">]. Other genes that were upregulated in our analysis include </offsets><italic><offsets xml_i="47199" xml_f="47203" txt_i="35033" txt_f="35037">BCL2</offsets></italic><offsets xml_i="47212" xml_f="47217" txt_i="35037" txt_f="35042"> and </offsets><italic><offsets xml_i="47225" xml_f="47233" txt_i="35042" txt_f="35050">TNF-AIP3</offsets></italic><offsets xml_i="47242" xml_f="47292" txt_i="35050" txt_f="35100">, which are known inhibitors of NF-κB signalling [</offsets><xref rid="B68-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47343" xml_f="47345" txt_i="35100" txt_f="35102">68</offsets></xref><offsets xml_i="47352" xml_f="47353" txt_i="35102" txt_f="35103">,</offsets><xref rid="B69-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47404" xml_f="47406" txt_i="35103" txt_f="35105">69</offsets></xref><offsets xml_i="47413" xml_f="47414" txt_i="35105" txt_f="35106">,</offsets><xref rid="B70-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47465" xml_f="47467" txt_i="35106" txt_f="35108">70</offsets></xref><offsets xml_i="47474" xml_f="47475" txt_i="35108" txt_f="35109">,</offsets><xref rid="B71-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47526" xml_f="47528" txt_i="35109" txt_f="35111">71</offsets></xref><offsets xml_i="47535" xml_f="47536" txt_i="35111" txt_f="35112">,</offsets><xref rid="B72-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47587" xml_f="47589" txt_i="35112" txt_f="35114">72</offsets></xref><offsets xml_i="47596" xml_f="47597" txt_i="35114" txt_f="35115">,</offsets><xref rid="B73-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47648" xml_f="47650" txt_i="35115" txt_f="35117">73</offsets></xref><offsets xml_i="47657" xml_f="47658" txt_i="35117" txt_f="35118">,</offsets><xref rid="B74-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47709" xml_f="47711" txt_i="35118" txt_f="35120">74</offsets></xref><offsets xml_i="47718" xml_f="47719" txt_i="35120" txt_f="35121">,</offsets><xref rid="B75-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47770" xml_f="47772" txt_i="35121" txt_f="35123">75</offsets></xref><offsets xml_i="47779" xml_f="47780" txt_i="35123" txt_f="35124">,</offsets><xref rid="B76-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47831" xml_f="47833" txt_i="35124" txt_f="35126">76</offsets></xref><offsets xml_i="47840" xml_f="47841" txt_i="35126" txt_f="35127">,</offsets><xref rid="B77-nutrients-09-00116" ref-type="bibr"><offsets xml_i="47892" xml_f="47894" txt_i="35127" txt_f="35129">77</offsets></xref><offsets xml_i="47901" xml_f="48027" txt_i="35129" txt_f="35251">]. Another gene found to be upregulated following intervention with the F&amp;V concentrate was ZFAND5, also known as ZNF216 [</offsets><xref rid="B78-nutrients-09-00116" ref-type="bibr"><offsets xml_i="48078" xml_f="48080" txt_i="35251" txt_f="35253">78</offsets></xref><offsets xml_i="48087" xml_f="48229" txt_i="35253" txt_f="35395">]. A previous study on ZFAND5 found that it was an inhibitor of NF-κB activation, by reducing TNFα, IL-1 and TLR4 in a dose-dependent manner [</offsets><xref rid="B79-nutrients-09-00116" ref-type="bibr"><offsets xml_i="48280" xml_f="48282" txt_i="35395" txt_f="35397">79</offsets></xref><offsets xml_i="48289" xml_f="48495" txt_i="35397" txt_f="35599">]. Hence, our data show several pathways by which the F&amp;V concentrate appears to be having an anti-inflammatory effect, with several AMPK and NF-κB signalling pathway genes contributing to this effect. </offsets></p><p><offsets xml_i="48502" xml_f="48663" txt_i="35600" txt_f="35757">F&amp;V concentrate supplementation has previously been shown to reduce homeostatic model assessment-insulin resistance (HOMA-IR) in a group of overweight boys [</offsets><xref rid="B50-nutrients-09-00116" ref-type="bibr"><offsets xml_i="48714" xml_f="48716" txt_i="35757" txt_f="35759">50</offsets></xref><offsets xml_i="48723" xml_f="49056" txt_i="35759" txt_f="36088">]. While there was no change in HbA1C in the intervention group in our study, pathways analysis using GATHER found that a number of genes involved in the insulin signalling pathway were upregulated following intervention with the F&amp;V concentrate. In the high baseline CRP subgroup analysis, the increased expression of the genes </offsets><italic><offsets xml_i="49064" xml_f="49101" txt_i="36088" txt_f="36125">HK2, IRS2, PDE3B, PHKB, PRKAG2, PTPN1</offsets></italic><offsets xml_i="49110" xml_f="49115" txt_i="36125" txt_f="36130"> and </offsets><italic><offsets xml_i="49123" xml_f="49127" txt_i="36130" txt_f="36134">RHEB</offsets></italic><offsets xml_i="49136" xml_f="49329" txt_i="36134" txt_f="36323"> suggests that the intervention with the F&amp;V concentrate increases insulin sensitivity, as these genes are all involved in reducing blood glucose levels via the insulin signalling pathway [</offsets><xref rid="B80-nutrients-09-00116" ref-type="bibr"><offsets xml_i="49380" xml_f="49382" txt_i="36323" txt_f="36325">80</offsets></xref><offsets xml_i="49389" xml_f="49390" txt_i="36325" txt_f="36326">,</offsets><xref rid="B81-nutrients-09-00116" ref-type="bibr"><offsets xml_i="49441" xml_f="49443" txt_i="36326" txt_f="36328">81</offsets></xref><offsets xml_i="49450" xml_f="49451" txt_i="36328" txt_f="36329">,</offsets><xref rid="B82-nutrients-09-00116" ref-type="bibr"><offsets xml_i="49502" xml_f="49504" txt_i="36329" txt_f="36331">82</offsets></xref><offsets xml_i="49511" xml_f="49512" txt_i="36331" txt_f="36332">,</offsets><xref rid="B83-nutrients-09-00116" ref-type="bibr"><offsets xml_i="49563" xml_f="49565" txt_i="36332" txt_f="36334">83</offsets></xref><offsets xml_i="49572" xml_f="49573" txt_i="36334" txt_f="36335">,</offsets><xref rid="B84-nutrients-09-00116" ref-type="bibr"><offsets xml_i="49624" xml_f="49626" txt_i="36335" txt_f="36337">84</offsets></xref><offsets xml_i="49633" xml_f="49634" txt_i="36337" txt_f="36338">,</offsets><xref rid="B85-nutrients-09-00116" ref-type="bibr"><offsets xml_i="49685" xml_f="49687" txt_i="36338" txt_f="36340">85</offsets></xref><offsets xml_i="49694" xml_f="49695" txt_i="36340" txt_f="36341">,</offsets><xref rid="B86-nutrients-09-00116" ref-type="bibr"><offsets xml_i="49746" xml_f="49748" txt_i="36341" txt_f="36343">86</offsets></xref><offsets xml_i="49755" xml_f="49885" txt_i="36343" txt_f="36469">]. This provides further evidence of the ability of the F&amp;V concentrate to improve the metabolic profile of obese individuals.</offsets></p><p><offsets xml_i="49892" xml_f="50138" txt_i="36470" txt_f="36712">Following the intervention with the F&amp;V concentrate, systolic blood pressure (SBP) was found to be reduced in the full cohort analysis. A previous observational study found there was an inverse relationship between β-carotene levels and SBP [</offsets><xref rid="B87-nutrients-09-00116" ref-type="bibr"><offsets xml_i="50189" xml_f="50191" txt_i="36712" txt_f="36714">87</offsets></xref><offsets xml_i="50198" xml_f="50334" txt_i="36714" txt_f="36850">]. In another intervention study, increasing fruit and vegetable consumption to at least five daily portions significantly reduced SBP [</offsets><xref rid="B88-nutrients-09-00116" ref-type="bibr"><offsets xml_i="50385" xml_f="50387" txt_i="36850" txt_f="36852">88</offsets></xref><offsets xml_i="50394" xml_f="50542" txt_i="36852" txt_f="37000">]. This reduction in SBP indicates a decreased risk of cardiovascular diseases, such as myocardial infarction, stroke and congestive heart failure [</offsets><xref rid="B15-nutrients-09-00116" ref-type="bibr"><offsets xml_i="50593" xml_f="50595" txt_i="37000" txt_f="37002">15</offsets></xref><offsets xml_i="50602" xml_f="50948" txt_i="37002" txt_f="37348">]. Interestingly, however, there was also a significant reduction in SBP in the placebo group. Hence, we cannot rule out the possibility that subjects in the trial experienced the ‘white coat effect’ prior to their baseline visit, with their blood pressure becoming elevated due to anxiety about attending the research centre for the first time [</offsets><xref rid="B89-nutrients-09-00116" ref-type="bibr"><offsets xml_i="50999" xml_f="51001" txt_i="37348" txt_f="37350">89</offsets></xref><offsets xml_i="51008" xml_f="51010" txt_i="37350" txt_f="37352">].</offsets></p><p><offsets xml_i="51017" xml_f="51286" txt_i="37353" txt_f="37618">F&amp;V concentrate supplementation led to an increase in total lean mass in both the full cohort analysis and the high baseline CRP subgroup analysis, likely due, at least in part, to the decrease in TNFα that we observed. TNFα plays a central role in muscle wasting [</offsets><xref rid="B90-nutrients-09-00116" ref-type="bibr"><offsets xml_i="51337" xml_f="51339" txt_i="37618" txt_f="37620">90</offsets></xref><offsets xml_i="51346" xml_f="51769" txt_i="37620" txt_f="38043">]. Circulating TNFα binds to peripheral muscle cell receptors, stimulating the production of reactive oxygen species (ROS) and cellular apoptosis. In addition, the receptor binding stimulates NF-κB activation, possibly enhanced by ROS. The result is protein loss, caused directly via increased ubiquitin activity and indirectly via decreased myogenic differentiation (MyoD) expression, which decreases myofibril synthesis [</offsets><xref rid="B90-nutrients-09-00116" ref-type="bibr"><offsets xml_i="51820" xml_f="51822" txt_i="38043" txt_f="38045">90</offsets></xref><offsets xml_i="51829" xml_f="51998" txt_i="38045" txt_f="38210">]. This observation suggests that F&amp;V concentrate supplementation may be beneficial in settings where muscle wasting is undesirable, e.g., during aging or cachexia. </offsets></p><p><offsets xml_i="52005" xml_f="52672" txt_i="38211" txt_f="38862">Baseline intake of fruit and vegetables was well below recommended levels for both the F&amp;V concentrate and placebo groups. Following the intervention with the F&amp;V concentrate, β-carotene and total carotenoids were significantly increased in the full cohort analysis, as well as the high baseline CRP subgroup analysis. α-tocopherol was found to be unchanged by the F&amp;V concentrate intervention. The F&amp;V concentrate used in this study provides a daily dose of 3.5 mg β-carotene and 4.8 mg α-tocopherol. These daily doses correspond approximately to 100% of the usual daily intake of β-carotene, but only ~50% of the usual daily intake of α-tocopherol [</offsets><xref rid="B3-nutrients-09-00116" ref-type="bibr"><offsets xml_i="52722" xml_f="52723" txt_i="38862" txt_f="38863">3</offsets></xref><offsets xml_i="52730" xml_f="53136" txt_i="38863" txt_f="39269">]. Hence, it is not surprising that we observed an increase in circulating levels of β-carotene, but not α-tocopherol. The supplement also contains polyphenols (at least 119 compounds), including ellagitannins, gallotannins, dihydrochalcones, flavan-3-ols including proanthocyanidins, flavanones, flavones, flavonols, anthocyanins, hydroxybenzoic acids, hydroxycinnamic acids, phenylethanoids and lignans [</offsets><xref rid="B34-nutrients-09-00116" ref-type="bibr"><offsets xml_i="53187" xml_f="53189" txt_i="39269" txt_f="39271">34</offsets></xref><offsets xml_i="53196" xml_f="53500" txt_i="39271" txt_f="39575">]. Whilst we were unable to analyse the circulating levels of these compounds or their metabolites in the samples from this study, it is likely that they would have contributed to the effects that we observed, as the dose delivered (~600 mg/day) is approaching the usual daily dose for most populations [</offsets><xref rid="B34-nutrients-09-00116" ref-type="bibr"><offsets xml_i="53551" xml_f="53553" txt_i="39575" txt_f="39577">34</offsets></xref><offsets xml_i="53560" xml_f="54216" txt_i="39577" txt_f="40233">]. As previously discussed, total carotenoids decreased in the placebo group following the eight-week intervention. This suggests that the two-week run-in period on the low fruit and vegetable washout diet was not long enough, and hence, carotenoids continued to decrease during the eight-week intervention period. Importantly, if the washout period was not adequate, this would also have affected the results in the intervention group, as the potential benefits of the supplement may have been masked, as background levels of carotenoids continued to wash out throughout the intervention period. In future trials, a longer wash out period is recommended. </offsets></p></sec><sec id="sec5-nutrients-09-00116"><title><offsets xml_i="54267" xml_f="54293" txt_i="40235" txt_f="40261">5. Summary and Conclusions</offsets></title><p><offsets xml_i="54304" xml_f="54834" txt_i="40262" txt_f="40788">To summarise, this randomised controlled trial in obese, older individuals shows that F&amp;V concentrate supplementation has the potential to improve the metabolic profile of overweight and obese individuals by reducing blood lipid levels and systemic inflammation, as well as improving body composition. The size of the improvements is clinically significant, as the reduction in total cholesterol that we observed in the full cohort is estimated to be equivalent to a weight loss of 4 kg and an 8% to 9% reduction in CVD risk [</offsets><xref rid="B48-nutrients-09-00116" ref-type="bibr"><offsets xml_i="54885" xml_f="54887" txt_i="40788" txt_f="40790">48</offsets></xref><offsets xml_i="54894" xml_f="54895" txt_i="40790" txt_f="40791">,</offsets><xref rid="B49-nutrients-09-00116" ref-type="bibr"><offsets xml_i="54946" xml_f="54948" txt_i="40791" txt_f="40793">49</offsets></xref><offsets xml_i="54955" xml_f="55153" txt_i="40793" txt_f="40991">]. In the subset of participants who had elevated systemic inflammation at baseline, the reduction in total cholesterol was equivalent to a 9 kg weight loss and an 18% to 19% reduction in CVD risk [</offsets><xref rid="B48-nutrients-09-00116" ref-type="bibr"><offsets xml_i="55204" xml_f="55206" txt_i="40991" txt_f="40993">48</offsets></xref><offsets xml_i="55213" xml_f="55214" txt_i="40993" txt_f="40994">,</offsets><xref rid="B49-nutrients-09-00116" ref-type="bibr"><offsets xml_i="55265" xml_f="55267" txt_i="40994" txt_f="40996">49</offsets></xref><offsets xml_i="55274" xml_f="55927" txt_i="40996" txt_f="41641">]. Interestingly, while significant changes were seen in the whole group of participants, the changes were more pronounced in subjects who had elevated CRP levels at baseline. Hence, while all obese individuals are likely to gain some benefit from supplementation with F&amp;V concentrate, those with high baseline systemic inflammation or blood lipids appear likely to obtain the greatest improvements. We conclude that in obese individuals, who typically have a low fruit and vegetable intake, F&amp;V concentrate supplementation may be beneficial for improving the metabolic profile, thus reducing the risk of developing chronic inflammatory disease.</offsets></p></sec></body><back><ack><title>Acknowledgments</title><p>The authors acknowledge the contribution of the Hunter Medical Research Institute Respiratory Research group sample processing team. Financial support for this project, including the supply of study supplements, was received from NSA LLC (Collierville, TN, USA). NSA LLC had no role in the design, analysis nor writing of this article.</p></ack><notes><title>Author Contributions</title><p>Evan Williams contributed to the data acquisition, analysis and interpretation, drafting of the manuscript and final approval of the version of the manuscript to be published. Katherine Baines contributed to the study design, data analysis and interpretation, manuscript review and final approval of the version to be published. Bronwyn Berthon contributed to the data acquisition, analysis and interpretation, manuscript review and final approval of the version to be published. Lisa Wood contributed to the study design, data analysis and interpretation, drafting of the manuscript and final approval of the version to be published.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-09-00116"><label>1.</label><element-citation publication-type="webpage">
<article-title>WHO Global Database on Body Mass Index</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/bmi/">http://apps.who.int/bmi/</ext-link></comment>
<date-in-citation>(accessed on 11 July 2013)</date-in-citation>
</element-citation></ref><ref id="B2-nutrients-09-00116"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogden</surname><given-names>C.L.</given-names></name><name><surname>Carroll</surname><given-names>M.D.</given-names></name><name><surname>Kit</surname><given-names>B.K.</given-names></name><name><surname>Flegal</surname><given-names>K.M.</given-names></name></person-group>
<article-title>PRevalence of childhood and adult obesity in the United States, 2011–2012</article-title>
<source>JAMA</source>
<year>2014</year>
<volume>311</volume>
<fpage>806</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2014.732</pub-id>
<pub-id pub-id-type="pmid">24570244</pub-id></element-citation></ref><ref id="B3-nutrients-09-00116"><label>3.</label><element-citation publication-type="book">
<person-group person-group-type="author"><collab>Australian Bureau of Statistics</collab></person-group>
<source>Australian Health Survey: Updated Results</source>
<publisher-name>Australian Bureau of Statistics</publisher-name>
<publisher-loc>Canberra, Australia</publisher-loc>
<year>2011–2012</year>
</element-citation></ref><ref id="B4-nutrients-09-00116"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Damcott</surname><given-names>C.M.</given-names></name><name><surname>Sack</surname><given-names>P.</given-names></name><name><surname>Shuldiner</surname><given-names>A.R.</given-names></name></person-group>
<article-title>The genetics of obesity</article-title>
<source>Endocrinol. Metab. Clin. N. Am.</source>
<year>2003</year>
<volume>32</volume>
<fpage>761</fpage>
<lpage>786</lpage>
<pub-id pub-id-type="doi">10.1016/S0889-8529(03)00076-8</pub-id>
</element-citation></ref><ref id="B5-nutrients-09-00116"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mraz</surname><given-names>M.</given-names></name><name><surname>Haluzik</surname><given-names>M.</given-names></name></person-group>
<article-title>The role of adipose tissue immune cells in obesity and low-grade inflammation</article-title>
<source>J. Endocrinol.</source>
<year>2014</year>
<volume>222</volume>
<fpage>R113</fpage>
<lpage>R127</lpage>
<pub-id pub-id-type="doi">10.1530/JOE-14-0283</pub-id>
<pub-id pub-id-type="pmid">25006217</pub-id></element-citation></ref><ref id="B6-nutrients-09-00116"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalupahana</surname><given-names>N.S.</given-names></name><name><surname>Moustaid-Moussa</surname><given-names>N.</given-names></name><name><surname>Claycombe</surname><given-names>K.J.</given-names></name></person-group>
<article-title>Immunity as a link between obesity and insulin resistance</article-title>
<source>Mol. Aspects Med.</source>
<year>2012</year>
<volume>33</volume>
<fpage>26</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1016/j.mam.2011.10.011</pub-id>
<pub-id pub-id-type="pmid">22040698</pub-id></element-citation></ref><ref id="B7-nutrients-09-00116"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lumeng</surname><given-names>C.N.</given-names></name><name><surname>Bodzin</surname><given-names>J.L.</given-names></name><name><surname>Saltiel</surname><given-names>A.R.</given-names></name></person-group>
<article-title>Obesity induces a phenotypic switch in adipose tissue macrophage polarization</article-title>
<source>J. Clin. Investig.</source>
<year>2007</year>
<volume>117</volume>
<fpage>175</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1172/JCI29881</pub-id>
<pub-id pub-id-type="pmid">17200717</pub-id></element-citation></ref><ref id="B8-nutrients-09-00116"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Siriwardhanaa</surname><given-names>N.</given-names></name><name><surname>Kalupahanab</surname><given-names>N.S.</given-names></name><name><surname>Cekanovac</surname><given-names>M.</given-names></name><name><surname>LeMieuxa</surname><given-names>M.</given-names></name><name><surname>Greerd</surname><given-names>B.</given-names></name><name><surname>Moustaid-Moussaa</surname><given-names>N.</given-names></name></person-group>
<article-title>Modulation of adipose tissue inflammation by bioactive food compounds</article-title>
<source>J. Nutr. Biochem.</source>
<year>2013</year>
<volume>24</volume>
<fpage>613</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="doi">10.1016/j.jnutbio.2012.12.013</pub-id>
<pub-id pub-id-type="pmid">23498665</pub-id></element-citation></ref><ref id="B9-nutrients-09-00116"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fantuzzi</surname><given-names>G.</given-names></name></person-group>
<article-title>Adipose tissue, adipokines, and inflammation</article-title>
<source>J. Allergy Clin. Immunol.</source>
<year>2005</year>
<volume>115</volume>
<fpage>911</fpage>
<lpage>919</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2005.02.023</pub-id>
<pub-id pub-id-type="pmid">15867843</pub-id></element-citation></ref><ref id="B10-nutrients-09-00116"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bulló</surname><given-names>M.</given-names></name><name><surname>Casas-Agustench</surname><given-names>P.</given-names></name><name><surname>Amigó-Correig</surname><given-names>P.</given-names></name><name><surname>Aranceta</surname><given-names>J.</given-names></name><name><surname>Salas-Salvadó</surname><given-names>J.</given-names></name></person-group>
<article-title>Inflammation, obesity and comorbidities: The role of diet</article-title>
<source>Public Health Nutr.</source>
<year>2007</year>
<volume>10</volume>
<fpage>1164</fpage>
<lpage>1172</lpage>
<pub-id pub-id-type="doi">10.1017/S1368980007000663</pub-id>
<pub-id pub-id-type="pmid">17903326</pub-id></element-citation></ref><ref id="B11-nutrients-09-00116"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poulain</surname><given-names>M.</given-names></name><name><surname>Doucet</surname><given-names>M.</given-names></name><name><surname>Major</surname><given-names>G.C.</given-names></name><name><surname>Drapeau</surname><given-names>V.</given-names></name><name><surname>Sériès</surname><given-names>F.</given-names></name><name><surname>Boulet</surname><given-names>L.-P.</given-names></name><name><surname>Tremblay</surname><given-names>A.</given-names></name><name><surname>Maltais</surname><given-names>F.</given-names></name></person-group>
<article-title>The effect of obesity on chronic respiratory diseases: Pathophysiology and therapeutic strategies</article-title>
<source>CMAJ</source>
<year>2006</year>
<volume>174</volume>
<fpage>1293</fpage>
<lpage>1299</lpage>
<pub-id pub-id-type="doi">10.1503/cmaj.051299</pub-id>
<pub-id pub-id-type="pmid">16636330</pub-id></element-citation></ref><ref id="B12-nutrients-09-00116"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cawthorn</surname><given-names>W.P.</given-names></name><name><surname>Sethi</surname><given-names>J.K.</given-names></name></person-group>
<article-title>TNF-α and adipocyte biology</article-title>
<source>FEBS Lett.</source>
<year>2008</year>
<volume>582</volume>
<fpage>117</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2007.11.051</pub-id>
<pub-id pub-id-type="pmid">18037376</pub-id></element-citation></ref><ref id="B13-nutrients-09-00116"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zarkesh-Esfahani</surname><given-names>H.</given-names></name><name><surname>Pockley</surname><given-names>A.G.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Hellewell</surname><given-names>P.G.</given-names></name><name><surname>Weetman</surname><given-names>A.P.</given-names></name><name><surname>Ross</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Leptin indirectly activates human neutrophils <italic>via</italic> induction of TNF-α</article-title>
<source>J. Immunol.</source>
<year>2004</year>
<volume>172</volume>
<fpage>1809</fpage>
<lpage>1814</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.172.3.1809</pub-id>
<pub-id pub-id-type="pmid">14734764</pub-id></element-citation></ref><ref id="B14-nutrients-09-00116"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Das</surname><given-names>U.N.</given-names></name></person-group>
<article-title>Is Obesity an Inflammatory Condition?</article-title>
<source>Nutrition</source>
<year>2001</year>
<volume>17</volume>
<fpage>953</fpage>
<lpage>966</lpage>
<pub-id pub-id-type="doi">10.1016/S0899-9007(01)00672-4</pub-id>
<pub-id pub-id-type="pmid">11744348</pub-id></element-citation></ref><ref id="B15-nutrients-09-00116"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vitseva</surname><given-names>O.I.</given-names></name><name><surname>Tanriverdi</surname><given-names>K.</given-names></name><name><surname>Tchkonia</surname><given-names>T.T.</given-names></name><name><surname>Kirkland</surname><given-names>J.L.</given-names></name><name><surname>McDonnell</surname><given-names>M.E.</given-names></name><name><surname>Apovian</surname><given-names>C.M.</given-names></name><name><surname>Freedman</surname><given-names>J.</given-names></name><name><surname>Gokce</surname><given-names>N.</given-names></name></person-group>
<article-title>Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue</article-title>
<source>Obesity (Silver Spring)</source>
<year>2008</year>
<volume>16</volume>
<fpage>932</fpage>
<lpage>937</lpage>
<pub-id pub-id-type="doi">10.1038/oby.2008.25</pub-id>
<pub-id pub-id-type="pmid">18292749</pub-id></element-citation></ref><ref id="B16-nutrients-09-00116"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bost</surname><given-names>F.</given-names></name><name><surname>Aouadi</surname><given-names>M.</given-names></name><name><surname>Caron</surname><given-names>L.</given-names></name><name><surname>Binetruy</surname><given-names>B.</given-names></name></person-group>
<article-title>The role of MAPKs in adipocyte differentiation and obesity</article-title>
<source>Biochimie</source>
<year>2005</year>
<volume>87</volume>
<fpage>51</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/j.biochi.2004.10.018</pub-id>
<pub-id pub-id-type="pmid">15733737</pub-id></element-citation></ref><ref id="B17-nutrients-09-00116"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>M.S.</given-names></name><name><surname>O’Brien</surname><given-names>E.L.</given-names></name><name><surname>Bigornia</surname><given-names>S.</given-names></name><name><surname>Mott</surname><given-names>M.</given-names></name><name><surname>Cacicedo</surname><given-names>J.M.</given-names></name><name><surname>Xu</surname><given-names>X.J.</given-names></name><name><surname>Gokce</surname><given-names>N.</given-names></name><name><surname>Apovian</surname><given-names>C.</given-names></name><name><surname>Ruderman</surname><given-names>N.</given-names></name></person-group>
<article-title>Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans</article-title>
<source>Biochem. Biophys. Res. Commun.</source>
<year>2011</year>
<volume>404</volume>
<fpage>382</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2010.11.127</pub-id>
<pub-id pub-id-type="pmid">21130749</pub-id></element-citation></ref><ref id="B18-nutrients-09-00116"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moller</surname><given-names>D.E.</given-names></name><name><surname>Berger</surname><given-names>J.P.</given-names></name></person-group>
<article-title>Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation</article-title>
<source>Int. J. Obes. Relat. Metab. Disord.</source>
<year>2003</year>
<volume>27</volume>
<fpage>S17</fpage>
<lpage>S21</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ijo.0802494</pub-id>
<pub-id pub-id-type="pmid">14704738</pub-id></element-citation></ref><ref id="B19-nutrients-09-00116"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dandona</surname><given-names>P.</given-names></name><name><surname>Aljada</surname><given-names>A.</given-names></name><name><surname>Bandyopadhyay</surname><given-names>A.</given-names></name></person-group>
<article-title>Inflammation: The link between insulin resistance, obesity and diabetes</article-title>
<source>Trends. Immunol.</source>
<year>2004</year>
<volume>25</volume>
<fpage>4</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2003.10.013</pub-id>
<pub-id pub-id-type="pmid">14698276</pub-id></element-citation></ref><ref id="B20-nutrients-09-00116"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Franks</surname><given-names>P.W.</given-names></name></person-group>
<article-title>Obesity, inflammatory markers and cardiovascular disease: Distinguishing causality from confounding</article-title>
<source>J. Hum. Hypertens</source>
<year>2006</year>
<volume>20</volume>
<fpage>837</fpage>
<lpage>840</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jhh.1002059</pub-id>
<pub-id pub-id-type="pmid">16855628</pub-id></element-citation></ref><ref id="B21-nutrients-09-00116"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nicklas</surname><given-names>B.J.</given-names></name><name><surname>Ambrosius</surname><given-names>W.</given-names></name><name><surname>Messier</surname><given-names>S.P.</given-names></name><name><surname>Miller</surname><given-names>G.D.</given-names></name><name><surname>Penninx</surname><given-names>B.W.J.H.</given-names></name><name><surname>Loeser</surname><given-names>R.F.</given-names></name><name><surname>Palla</surname><given-names>S.</given-names></name><name><surname>Bleecker</surname><given-names>E.</given-names></name><name><surname>Pahor</surname><given-names>M.</given-names></name></person-group>
<article-title>Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: A randomized controlled clinical trial</article-title>
<source>Am. J. Clin. Nutr.</source>
<year>2004</year>
<volume>79</volume>
<fpage>544</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="pmid">15051595</pub-id></element-citation></ref><ref id="B22-nutrients-09-00116"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>L.K.</given-names></name><name><surname>Wallace</surname><given-names>J.M.</given-names></name><name><surname>Livingstone</surname><given-names>M.B.E.</given-names></name></person-group>
<article-title>Obesity and inflammation: The effects of weight loss</article-title>
<source>Nutr. Res. Rev.</source>
<year>2008</year>
<volume>21</volume>
<fpage>117</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1017/S0954422408138732</pub-id>
<pub-id pub-id-type="pmid">19087366</pub-id></element-citation></ref><ref id="B23-nutrients-09-00116"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jung</surname><given-names>S.H.</given-names></name><name><surname>Park</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>K.-S.</given-names></name><name><surname>Choi</surname><given-names>W.H.</given-names></name><name><surname>Ahn</surname><given-names>C.W.</given-names></name><name><surname>Kim</surname><given-names>B.T.</given-names></name><name><surname>Kim</surname><given-names>S.M.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Ahn</surname><given-names>S.M.</given-names></name><name><surname>Kim</surname><given-names>Y.K.</given-names></name><etal></etal></person-group>
<article-title>Effect of weight loss on some serum cytokines in human obesity: Increase in IL-10 after weight loss</article-title>
<source>J. Nutr. Biochem.</source>
<year>2008</year>
<volume>19</volume>
<fpage>371</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1016/j.jnutbio.2007.05.007</pub-id>
<pub-id pub-id-type="pmid">17614271</pub-id></element-citation></ref><ref id="B24-nutrients-09-00116"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barinas-Mitchell</surname><given-names>E.</given-names></name><name><surname>Kuller</surname><given-names>L.H.</given-names></name><name><surname>Sutton-Tyrrell</surname><given-names>K.</given-names></name><name><surname>Hegazi</surname><given-names>R.</given-names></name><name><surname>Harper</surname><given-names>P.</given-names></name><name><surname>Mancino</surname><given-names>J.</given-names></name><name><surname>Kelley</surname><given-names>D.E.</given-names></name></person-group>
<article-title>Effect of Weight Loss and Nutritional Intervention on Arterial Stiffness in Type 2 Diabetes</article-title>
<source>Diabetes Care</source>
<year>2006</year>
<volume>29</volume>
<fpage>2218</fpage>
<lpage>2222</lpage>
<pub-id pub-id-type="doi">10.2337/dc06-0665</pub-id>
<pub-id pub-id-type="pmid">17003296</pub-id></element-citation></ref><ref id="B25-nutrients-09-00116"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marfella</surname><given-names>R.</given-names></name><name><surname>Esposito</surname><given-names>K.</given-names></name><name><surname>Siniscalchi</surname><given-names>M.</given-names></name><name><surname>Cacciapuoti</surname><given-names>F.</given-names></name><name><surname>Giugliano</surname><given-names>F.</given-names></name><name><surname>Labriloa</surname><given-names>D.</given-names></name><name><surname>Ciotola</surname><given-names>M.</given-names></name><name><surname>Di Palo</surname><given-names>C.</given-names></name><name><surname>Misso</surname><given-names>L.</given-names></name><name><surname>Giugliano</surname><given-names>D.</given-names></name></person-group>
<article-title>Effect of Weight Loss on Cardiac Synchronization and Proinflammatory Cytokines in Premenopausal Obese Women</article-title>
<source>Diabetes Care</source>
<year>2004</year>
<volume>27</volume>
<fpage>47</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.2337/diacare.27.1.47</pub-id>
<pub-id pub-id-type="pmid">14693965</pub-id></element-citation></ref><ref id="B26-nutrients-09-00116"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selvin</surname><given-names>E.</given-names></name><name><surname>Paynter</surname><given-names>N.P.</given-names></name><name><surname>Erlinger</surname><given-names>T.P.</given-names></name></person-group>
<article-title>The Effect of Weight Loss on C-Reactive Protein: A Systematic Review</article-title>
<source>Arch. Intern. Med.</source>
<year>2007</year>
<volume>167</volume>
<fpage>31</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1001/archinte.167.1.31</pub-id>
<pub-id pub-id-type="pmid">17210875</pub-id></element-citation></ref><ref id="B27-nutrients-09-00116"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Barger</surname><given-names>J.L.</given-names></name><name><surname>Page</surname><given-names>G.P.</given-names></name><name><surname>Allison</surname><given-names>D.B.</given-names></name><name><surname>Smith</surname><given-names>S.R.</given-names></name><name><surname>Prolla</surname><given-names>T.A.</given-names></name><name><surname>Weindruch</surname><given-names>R.</given-names></name></person-group>
<article-title>Energy restriction lowers the expression of genes linked to inflammation, the cytoskeleton, the extracellular matrix, and angiogenesis in mouse adipose tissue</article-title>
<source>J. Nutr.</source>
<year>2006</year>
<volume>136</volume>
<fpage>343</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">16424110</pub-id></element-citation></ref><ref id="B28-nutrients-09-00116"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larson-Meyer</surname><given-names>D.E.</given-names></name><name><surname>Heilbronn</surname><given-names>L.K.</given-names></name><name><surname>Redman</surname><given-names>L.M.</given-names></name><name><surname>Newcomer</surname><given-names>B.R.</given-names></name><name><surname>Frisard</surname><given-names>M.I.</given-names></name><name><surname>Anton</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>S.R.</given-names></name><name><surname>Alfonso</surname><given-names>A.</given-names></name><name><surname>Ravussin</surname><given-names>E.</given-names></name></person-group>
<article-title>Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects</article-title>
<source>Diabetes Care</source>
<year>2006</year>
<volume>29</volume>
<fpage>1337</fpage>
<lpage>1344</lpage>
<pub-id pub-id-type="doi">10.2337/dc05-2565</pub-id>
<pub-id pub-id-type="pmid">16732018</pub-id></element-citation></ref><ref id="B29-nutrients-09-00116"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jarvi</surname><given-names>A.</given-names></name><name><surname>Karlstrom</surname><given-names>B.</given-names></name><name><surname>Vessby</surname><given-names>B.</given-names></name><name><surname>Becker</surname><given-names>W.</given-names></name></person-group>
<article-title>Increased intake of fruits and vegetables in overweight subjects: Effects on body weight, body composition, metabolic risk factors and dietary intake</article-title>
<source>Br. J. Nutr.</source>
<year>2016</year>
<volume>115</volume>
<fpage>1760</fpage>
<lpage>1768</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114516000970</pub-id>
<pub-id pub-id-type="pmid">26996228</pub-id></element-citation></ref><ref id="B30-nutrients-09-00116"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alvarez-Suarez</surname><given-names>J.M.</given-names></name><name><surname>Giampieri</surname><given-names>F.</given-names></name><name><surname>Tulipani</surname><given-names>S.</given-names></name><name><surname>Casoli</surname><given-names>T.</given-names></name><name><surname>Di Stefano</surname><given-names>G.</given-names></name><name><surname>González-Paramás</surname><given-names>A.M.</given-names></name><name><surname>Santos-Buelga</surname><given-names>C.</given-names></name><name><surname>Busco</surname><given-names>F.</given-names></name><name><surname>Quiles</surname><given-names>J.L.</given-names></name><name><surname>Cordero</surname><given-names>M.D.</given-names></name><etal></etal></person-group>
<article-title>One-month strawberry-rich anthocyanin supplementation ameliorates cardiovascular risk, oxidative stress markers and platelet activation in humans</article-title>
<source>J. Nutr. Biochem.</source>
<year>2014</year>
<volume>25</volume>
<fpage>289</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1016/j.jnutbio.2013.11.002</pub-id>
<pub-id pub-id-type="pmid">24406274</pub-id></element-citation></ref><ref id="B31-nutrients-09-00116"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esfahani</surname><given-names>A.</given-names></name><name><surname>Wong</surname><given-names>J.M.</given-names></name><name><surname>Truan</surname><given-names>J.</given-names></name><name><surname>Villa</surname><given-names>C.R.</given-names></name><name><surname>Mirrahimi</surname><given-names>A.</given-names></name><name><surname>Srichaikul</surname><given-names>K.</given-names></name><name><surname>Kendall</surname><given-names>C.W.</given-names></name></person-group>
<article-title>Health effects of mixed fruit and vegetable concentrates: A systematic review of the clinical interventions</article-title>
<source>J. Am. Coll. Nutr.</source>
<year>2011</year>
<volume>30</volume>
<fpage>285</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1080/07315724.2011.10719971</pub-id>
<pub-id pub-id-type="pmid">22081614</pub-id></element-citation></ref><ref id="B32-nutrients-09-00116"><label>32.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Heale</surname><given-names>P.</given-names></name><name><surname>Stockwell</surname><given-names>T.</given-names></name><name><surname>Dietze</surname><given-names>P.</given-names></name><name><surname>Chikritzhs</surname><given-names>T.</given-names></name><name><surname>Catalano</surname><given-names>P.</given-names></name></person-group>
<source>Patterns of Alcohol Consumption in Australia, 1998</source>
<comment>National Alcohol Indicators Project, Bulletin No. 3. National Drug Research Institute</comment>
<publisher-name>Curtin University of Technology</publisher-name>
<publisher-loc>Perth, Australia</publisher-loc>
<year>2000</year>
</element-citation></ref><ref id="B33-nutrients-09-00116"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lamprecht</surname><given-names>M.</given-names></name><name><surname>Obermayer</surname><given-names>G.</given-names></name><name><surname>Steinbauer</surname><given-names>K.</given-names></name><name><surname>Cvirn</surname><given-names>G.</given-names></name><name><surname>Hofmann</surname><given-names>L.</given-names></name><name><surname>Ledinski</surname><given-names>G.</given-names></name><name><surname>Greilberger</surname><given-names>J.F.</given-names></name><name><surname>Hallstroem</surname><given-names>S.</given-names></name></person-group>
<article-title>Supplementation with a juice powder concentrate and exercise decrease oxidation and inflammation, and improve the microcirculation in obese women: Randomised controlled trial data</article-title>
<source>Br. J. Nutr.</source>
<year>2013</year>
<volume>110</volume>
<fpage>1685</fpage>
<lpage>1695</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114513001001</pub-id>
<pub-id pub-id-type="pmid">23591157</pub-id></element-citation></ref><ref id="B34-nutrients-09-00116"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bresciani</surname><given-names>L.</given-names></name><name><surname>Calani</surname><given-names>L.</given-names></name><name><surname>Cossu</surname><given-names>M.</given-names></name><name><surname>Mena</surname><given-names>P.</given-names></name><name><surname>Sayegh</surname><given-names>M.</given-names></name><name><surname>Ray</surname><given-names>S.</given-names></name><name><surname>Del Rio</surname><given-names>D.</given-names></name></person-group>
<article-title>(Poly)phenolic characterization of three food supplements containing 36 different fruits, vegetables and berries</article-title>
<source>PharmaNutrition</source>
<year>2015</year>
<volume>3</volume>
<fpage>11</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1016/j.phanu.2015.01.001</pub-id>
</element-citation></ref><ref id="B35-nutrients-09-00116"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ware</surname><given-names>J.E.</given-names><suffix>Jr.</suffix></name><name><surname>Sherbourne</surname><given-names>C.D.</given-names></name></person-group>
<article-title>The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection</article-title>
<source>Med. Care</source>
<year>1992</year>
<volume>30</volume>
<fpage>473</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="doi">10.1097/00005650-199206000-00002</pub-id>
<pub-id pub-id-type="pmid">1593914</pub-id></element-citation></ref><ref id="B36-nutrients-09-00116"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>L.G.</given-names></name><name><surname>Gibson</surname><given-names>P.G.</given-names></name></person-group>
<article-title>Reduced circulating antioxidant defences are associated with airway hyper-responsiveness, poor control and severe disease pattern in asthma</article-title>
<source>Br. J. Nutr.</source>
<year>2010</year>
<volume>103</volume>
<fpage>735</fpage>
<lpage>741</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114509992376</pub-id>
<pub-id pub-id-type="pmid">19874635</pub-id></element-citation></ref><ref id="B37-nutrients-09-00116"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>L.G.</given-names></name><name><surname>Garg</surname><given-names>M.L.</given-names></name><name><surname>Powell</surname><given-names>H.</given-names></name><name><surname>Gibson</surname><given-names>P.G.</given-names></name></person-group>
<article-title>Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: Proof of concept</article-title>
<source>Free Radic. Res.</source>
<year>2008</year>
<volume>42</volume>
<fpage>94</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1080/10715760701767307</pub-id>
<pub-id pub-id-type="pmid">18324527</pub-id></element-citation></ref><ref id="B38-nutrients-09-00116"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>L.G.</given-names></name><name><surname>Garg</surname><given-names>M.L.</given-names></name><name><surname>Blake</surname><given-names>R.J.</given-names></name><name><surname>Garcia-Caraballo</surname><given-names>S.</given-names></name><name><surname>Gibson</surname><given-names>P.G.</given-names></name></person-group>
<article-title>Airway and circulating levels of carotenoids in asthma and healthy controls</article-title>
<source>J. Am. Coll. Nutr.</source>
<year>2005</year>
<volume>24</volume>
<fpage>448</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="doi">10.1080/07315724.2005.10719490</pub-id>
<pub-id pub-id-type="pmid">16373941</pub-id></element-citation></ref><ref id="B39-nutrients-09-00116"><label>39.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Giles</surname><given-names>G.</given-names></name><name><surname>Ireland</surname><given-names>P.</given-names></name></person-group>
<source>Dietary Questionnaire for Epidemiological Studies</source>
<comment>version 2</comment>
<publisher-name>The Cancer Council Victoria</publisher-name>
<publisher-loc>Melbourne, Australia</publisher-loc>
<year>1996</year>
</element-citation></ref><ref id="B40-nutrients-09-00116"><label>40.</label><element-citation publication-type="book">
<person-group person-group-type="author"><collab>National Health and Medical Research Council</collab></person-group>
<source>Australian Dietary Guidelines</source>
<publisher-name>National Health and Medical Research Council</publisher-name>
<publisher-loc>Canberra, Australia</publisher-loc>
<year>2013</year>
</element-citation></ref><ref id="B41-nutrients-09-00116"><label>41.</label><element-citation publication-type="webpage">
<person-group person-group-type="author"><collab>National Center for Biotechnology Information</collab></person-group>
<article-title>Gene Expression Omnibus (GEO)</article-title>
<year>2017</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87454">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87454</ext-link></comment>
<date-in-citation>(accessed on 8 September 2016)</date-in-citation>
</element-citation></ref><ref id="B42-nutrients-09-00116"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andersen</surname><given-names>C.L.</given-names></name><name><surname>Jensen</surname><given-names>J.L.</given-names></name><name><surname>Orntoft</surname><given-names>T.F.</given-names></name></person-group>
<article-title>Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets</article-title>
<source>Cancer Res.</source>
<year>2004</year>
<volume>64</volume>
<fpage>5245</fpage>
<lpage>5250</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-0496</pub-id>
<pub-id pub-id-type="pmid">15289330</pub-id></element-citation></ref><ref id="B43-nutrients-09-00116"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dupont</surname><given-names>W.D.</given-names></name><name><surname>Plummer</surname><given-names>W.D.</given-names></name></person-group>
<article-title>Power and Sample Size Calculations for Studies Involving Linear Regression</article-title>
<source>Controll. Clin. Trials</source>
<year>1998</year>
<volume>19</volume>
<fpage>589</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="doi">10.1016/S0197-2456(98)00037-3</pub-id>
</element-citation></ref><ref id="B44-nutrients-09-00116"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Du</surname><given-names>P.</given-names></name><name><surname>Kibbe</surname><given-names>W.A.</given-names></name><name><surname>Lin</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Lumi: A pipeline for processing Illumina microarray</article-title>
<source>Bioinformatics</source>
<year>2008</year>
<volume>24</volume>
<fpage>1547</fpage>
<lpage>1548</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btn224</pub-id>
<pub-id pub-id-type="pmid">18467348</pub-id></element-citation></ref><ref id="B45-nutrients-09-00116"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>M.E.</given-names></name><name><surname>Phipson</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Law</surname><given-names>C.W.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Smyth</surname><given-names>G.K.</given-names></name></person-group>
<article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>
<source>Nucl. Acids Res.</source>
<year>2015</year>
<volume>43</volume>
<fpage>e47</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
<pub-id pub-id-type="pmid">25605792</pub-id></element-citation></ref><ref id="B46-nutrients-09-00116"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>J.T.</given-names></name><name><surname>Nevins</surname><given-names>J.R.</given-names></name></person-group>
<article-title>GATHER: A systems approach to interpreting genomic signatures</article-title>
<source>Bioinformatics</source>
<year>2006</year>
<volume>22</volume>
<fpage>2926</fpage>
<lpage>2933</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btl483</pub-id>
<pub-id pub-id-type="pmid">17000751</pub-id></element-citation></ref><ref id="B47-nutrients-09-00116"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rees</surname><given-names>K.</given-names></name><name><surname>Dyakova</surname><given-names>M.</given-names></name><name><surname>Ward</surname><given-names>K.</given-names></name><name><surname>Thorogood</surname><given-names>M.</given-names></name><name><surname>Brunner</surname><given-names>E.</given-names></name></person-group>
<article-title>Dietary advice for reducing cardiovascular risk</article-title>
<source>Cochrane Database Syst. Rev.</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1002/14651858.CD002128</pub-id>
</element-citation></ref><ref id="B48-nutrients-09-00116"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anderson</surname><given-names>J.W.</given-names></name><name><surname>Konz</surname><given-names>E.C.</given-names></name></person-group>
<article-title>Obesity and disease management: Effects of weight loss on comorbid conditions</article-title>
<source>Obes. Res.</source>
<year>2001</year>
<volume>9</volume>
<fpage>326S</fpage>
<lpage>334S</lpage>
<pub-id pub-id-type="doi">10.1038/oby.2001.138</pub-id>
<pub-id pub-id-type="pmid">11707561</pub-id></element-citation></ref><ref id="B49-nutrients-09-00116"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dattilo</surname><given-names>A.M.</given-names></name><name><surname>Kris-Etherton</surname><given-names>P.M.</given-names></name></person-group>
<article-title>Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis</article-title>
<source>Am. J. Clin. Nutr.</source>
<year>1992</year>
<volume>56</volume>
<fpage>320</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="pmid">1386186</pub-id></element-citation></ref><ref id="B50-nutrients-09-00116"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canas</surname><given-names>J.A.</given-names></name><name><surname>Damaso</surname><given-names>L.</given-names></name><name><surname>Altomare</surname><given-names>A.</given-names></name><name><surname>Killen</surname><given-names>K.</given-names></name><name><surname>Hossain</surname><given-names>J.</given-names></name><name><surname>Balagopal</surname><given-names>P.</given-names></name></person-group>
<article-title>Insulin resistance and adiposity in relation to serum beta-carotene levels</article-title>
<source>J. Pediatr.</source>
<year>2012</year>
<volume>161</volume>
<fpage>58</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2012.01.030</pub-id>
<pub-id pub-id-type="pmid">22381025</pub-id></element-citation></ref><ref id="B51-nutrients-09-00116"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Annuzzi</surname><given-names>G.</given-names></name><name><surname>Bozzetto</surname><given-names>L.</given-names></name><name><surname>Costabile</surname><given-names>G.</given-names></name><name><surname>Giacco</surname><given-names>R.</given-names></name><name><surname>Mangione</surname><given-names>A.</given-names></name><name><surname>Anniballi</surname><given-names>G.</given-names></name><name><surname>Vitale</surname><given-names>M.</given-names></name><name><surname>Vetrani</surname><given-names>C.</given-names></name><name><surname>Cipriano</surname><given-names>P.</given-names></name><name><surname>Della Corte</surname><given-names>G.</given-names></name><etal></etal></person-group>
<article-title>Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: A randomized controlled trial</article-title>
<source>Am. J. Clin. Nutr.</source>
<year>2014</year>
<volume>99</volume>
<fpage>463</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.113.073445</pub-id>
<pub-id pub-id-type="pmid">24368433</pub-id></element-citation></ref><ref id="B52-nutrients-09-00116"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olivier</surname><given-names>L.M.</given-names></name><name><surname>Chambliss</surname><given-names>K.L.</given-names></name><name><surname>Michael Gibson</surname><given-names>K.</given-names></name><name><surname>Krisans</surname><given-names>S.K.</given-names></name></person-group>
<article-title>Characterization of phosphomevalonate kinase: Chromosomal localization, regulation, and subcellular targeting</article-title>
<source>J. Lipid Res.</source>
<year>1999</year>
<volume>40</volume>
<fpage>672</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="pmid">10191291</pub-id></element-citation></ref><ref id="B53-nutrients-09-00116"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aripirala</surname><given-names>S.</given-names></name><name><surname>Gonzalez-Pacanowska</surname><given-names>D.</given-names></name><name><surname>Oldfield</surname><given-names>E.</given-names></name><name><surname>Kaiser</surname><given-names>M.</given-names></name><name><surname>Amzel</surname><given-names>L.M.</given-names></name><name><surname>Gabelli</surname><given-names>S.B.</given-names></name></person-group>
<article-title>Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates</article-title>
<source>Acta Crystallogr. Sect. D Biol. Crystallogr.</source>
<year>2014</year>
<volume>70</volume>
<fpage>802</fpage>
<lpage>810</lpage>
<pub-id pub-id-type="doi">10.1107/S1399004713033221</pub-id>
<pub-id pub-id-type="pmid">24598749</pub-id></element-citation></ref><ref id="B54-nutrients-09-00116"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canas</surname><given-names>J.A.</given-names></name><name><surname>Damaso</surname><given-names>L.</given-names></name><name><surname>Hossain</surname><given-names>J.</given-names></name><name><surname>Balagopal</surname><given-names>P.B.</given-names></name></person-group>
<article-title>Fatty acid binding proteins 4 and 5 in overweight prepubertal boys: Effect of nutritional counselling and supplementation with an encapsulated fruit and vegetable juice concentrate</article-title>
<source>J. Nutr. Sci.</source>
<year>2015</year>
<volume>4</volume>
<fpage>e39</fpage>
<pub-id pub-id-type="doi">10.1017/jns.2015.29</pub-id>
<pub-id pub-id-type="pmid">26688725</pub-id></element-citation></ref><ref id="B55-nutrients-09-00116"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esposito</surname><given-names>K.</given-names></name><name><surname>Marfella</surname><given-names>R.</given-names></name><name><surname>Ciotola</surname><given-names>M.</given-names></name><name><surname>Di Palo</surname><given-names>C.</given-names></name><name><surname>Giugliano</surname><given-names>F.</given-names></name><name><surname>Giugliano</surname><given-names>G.</given-names></name><name><surname>D’Armiento</surname><given-names>M.</given-names></name><name><surname>D’Andrea</surname><given-names>F.</given-names></name><name><surname>Giugliano</surname><given-names>D.</given-names></name></person-group>
<article-title>Effect of Mediterranean-Style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome</article-title>
<source>JAMA</source>
<year>2004</year>
<volume>292</volume>
<fpage>1440</fpage>
<lpage>1446</lpage>
<pub-id pub-id-type="doi">10.1001/jama.292.12.1440</pub-id>
<pub-id pub-id-type="pmid">15383514</pub-id></element-citation></ref><ref id="B56-nutrients-09-00116"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Watzl</surname><given-names>B.</given-names></name><name><surname>Kulling</surname><given-names>S.E.</given-names></name><name><surname>Moseneder</surname><given-names>J.</given-names></name><name><surname>Barth</surname><given-names>S.W.</given-names></name><name><surname>Bub</surname><given-names>A.</given-names></name></person-group>
<article-title>A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men</article-title>
<source>Am. J. Clin. Nutr.</source>
<year>2005</year>
<volume>82</volume>
<fpage>1052</fpage>
<lpage>1058</lpage>
<pub-id pub-id-type="pmid">16280438</pub-id></element-citation></ref><ref id="B57-nutrients-09-00116"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>X.</given-names></name><name><surname>Singh</surname><given-names>U.P.</given-names></name><name><surname>Chumanevich</surname><given-names>A.A.</given-names></name><name><surname>Harmon</surname><given-names>B.</given-names></name><name><surname>Cavicchia</surname><given-names>P.</given-names></name><name><surname>Hofseth</surname><given-names>A.B.</given-names></name><name><surname>Kotakadi</surname><given-names>V.</given-names></name><name><surname>Stroud</surname><given-names>B.</given-names></name><name><surname>Volate</surname><given-names>S.R.</given-names></name><etal></etal></person-group>
<article-title>Systemic inflammatory load in humans is suppressed by consumption of two formulations of dried, encapsulated juice concentrate</article-title>
<source>Mol. Nutr. Food Res.</source>
<year>2010</year>
<volume>54</volume>
<fpage>1506</fpage>
<lpage>1514</lpage>
<pub-id pub-id-type="doi">10.1002/mnfr.200900579</pub-id>
<pub-id pub-id-type="pmid">20425759</pub-id></element-citation></ref><ref id="B58-nutrients-09-00116"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seif El-Din</surname><given-names>S.H.</given-names></name><name><surname>El-Lakkany</surname><given-names>N.M.</given-names></name><name><surname>El-Naggar</surname><given-names>A.A.</given-names></name><name><surname>Hammam</surname><given-names>O.A.</given-names></name><name><surname>Abd El-Latif</surname><given-names>H.A.</given-names></name><name><surname>Ain-Shoka</surname><given-names>A.A.</given-names></name><name><surname>Ebeid</surname><given-names>F.A.</given-names></name></person-group>
<article-title>Effects of rosuvastatin and/or beta-carotene on non-alcoholic fatty liver in rats</article-title>
<source>Res. Pharm. Sci.</source>
<year>2015</year>
<volume>10</volume>
<fpage>275</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="pmid">26600855</pub-id></element-citation></ref><ref id="B59-nutrients-09-00116"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bai</surname><given-names>S.K.</given-names></name><name><surname>Lee</surname><given-names>S.J.</given-names></name><name><surname>Na</surname><given-names>H.J.</given-names></name><name><surname>Ha</surname><given-names>K.S.</given-names></name><name><surname>Han</surname><given-names>J.A.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Kwon</surname><given-names>Y.G.</given-names></name><name><surname>Chung</surname><given-names>C.K.</given-names></name><name><surname>Kim</surname><given-names>Y.M.</given-names></name></person-group>
<article-title>beta-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation</article-title>
<source>Exp. Mol. Med.</source>
<year>2005</year>
<volume>37</volume>
<fpage>323</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1038/emm.2005.42</pub-id>
<pub-id pub-id-type="pmid">16155409</pub-id></element-citation></ref><ref id="B60-nutrients-09-00116"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salminen</surname><given-names>A.</given-names></name><name><surname>Hyttinen</surname><given-names>J.M.T.</given-names></name><name><surname>Kaarniranta</surname><given-names>K.</given-names></name></person-group>
<article-title>AMP-activated protein kinase inhibits NF-κB signaling and inflammation: Impact on healthspan and lifespan</article-title>
<source>J. Mol. Med.</source>
<year>2011</year>
<volume>89</volume>
<fpage>667</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="doi">10.1007/s00109-011-0748-0</pub-id>
<pub-id pub-id-type="pmid">21431325</pub-id></element-citation></ref><ref id="B61-nutrients-09-00116"><label>61.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lage</surname><given-names>R.</given-names></name><name><surname>Dieguez</surname><given-names>C.</given-names></name><name><surname>Vidal-Puig</surname><given-names>A.</given-names></name><name><surname>Lopez</surname><given-names>M.</given-names></name></person-group>
<article-title>AMPK: A metabolic gauge regulating whole-body energy homeostasis</article-title>
<source>Trends Mol. Med.</source>
<year>2008</year>
<volume>14</volume>
<fpage>539</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2008.09.007</pub-id>
<pub-id pub-id-type="pmid">18977694</pub-id></element-citation></ref><ref id="B62-nutrients-09-00116"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ruderman</surname><given-names>N.B.</given-names></name><name><surname>Cacicedo</surname><given-names>J.M.</given-names></name><name><surname>Itani</surname><given-names>S.</given-names></name><name><surname>Yagihashi</surname><given-names>N.</given-names></name><name><surname>Saha</surname><given-names>A.K.</given-names></name><name><surname>Ye</surname><given-names>J.M.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Zou</surname><given-names>M.</given-names></name><name><surname>Carling</surname><given-names>D.</given-names></name><name><surname>Boden</surname><given-names>G.</given-names></name><etal></etal></person-group>
<article-title>Malonyl-CoA and AMP-activated protein kinase (AMPK): Possible links between insulin resistance in muscle and early endothelial cell damage in diabetes</article-title>
<source>Biochem. Soc. Trans.</source>
<year>2003</year>
<volume>31</volume>
<fpage>202</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1042/bst0310202</pub-id>
<pub-id pub-id-type="pmid">12546685</pub-id></element-citation></ref><ref id="B63-nutrients-09-00116"><label>63.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vinué</surname><given-names>Á.</given-names></name><name><surname>Andrés-Blasco</surname><given-names>I.</given-names></name><name><surname>Herrero-Cervera</surname><given-names>A.</given-names></name><name><surname>Piqueras</surname><given-names>L.</given-names></name><name><surname>Andrés</surname><given-names>V.</given-names></name><name><surname>Burks</surname><given-names>D.J.</given-names></name><name><surname>Sanz</surname><given-names>M.J.</given-names></name><name><surname>González-Navarro</surname><given-names>H.</given-names></name></person-group>
<article-title>Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling</article-title>
<source>Biochim. Biophys. Acta (BBA) Mol. Basis Dis.</source>
<year>2015</year>
<volume>1852</volume>
<fpage>1729</fpage>
<lpage>1742</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2015.05.013</pub-id>
<pub-id pub-id-type="pmid">26022372</pub-id></element-citation></ref><ref id="B64-nutrients-09-00116"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hur</surname><given-names>W.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>S.W.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Bae</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Hwang</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Park</surname><given-names>T.</given-names></name><name><surname>Um</surname><given-names>S.J.</given-names></name><etal></etal></person-group>
<article-title>Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway</article-title>
<source>Int. J. Biochem. Cell Biol.</source>
<year>2015</year>
<volume>64</volume>
<fpage>265</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocel.2015.04.016</pub-id>
<pub-id pub-id-type="pmid">25957914</pub-id></element-citation></ref><ref id="B65-nutrients-09-00116"><label>65.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoshizaki</surname><given-names>T.</given-names></name><name><surname>Schenk</surname><given-names>S.</given-names></name><name><surname>Imamura</surname><given-names>T.</given-names></name><name><surname>Babendure</surname><given-names>J.L.</given-names></name><name><surname>Sonoda</surname><given-names>N.</given-names></name><name><surname>Bae</surname><given-names>E.J.</given-names></name><name><surname>Oh</surname><given-names>D.Y.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Milne</surname><given-names>J.C.</given-names></name><name><surname>Westphal</surname><given-names>C.</given-names></name><etal></etal></person-group>
<article-title>SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity</article-title>
<source>Am. J. Physiol. Endocrinol. Metab.</source>
<year>2010</year>
<volume>298</volume>
<fpage>E419</fpage>
<lpage>E428</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00417.2009</pub-id>
<pub-id pub-id-type="pmid">19996381</pub-id></element-citation></ref><ref id="B66-nutrients-09-00116"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salminen</surname><given-names>A.</given-names></name><name><surname>Kauppinen</surname><given-names>A.</given-names></name><name><surname>Suuronen</surname><given-names>T.</given-names></name><name><surname>Kaarniranta</surname><given-names>K.</given-names></name></person-group>
<article-title>SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: Regulation of aging via NF-kappaB acetylation?</article-title>
<source>Bioessays</source>
<year>2008</year>
<volume>30</volume>
<fpage>939</fpage>
<lpage>942</lpage>
<pub-id pub-id-type="doi">10.1002/bies.20799</pub-id>
<pub-id pub-id-type="pmid">18800364</pub-id></element-citation></ref><ref id="B67-nutrients-09-00116"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Feldser</surname><given-names>H.G.</given-names></name><name><surname>Lainez</surname><given-names>E.</given-names></name><name><surname>Miller</surname><given-names>C.</given-names></name><name><surname>Leung</surname><given-names>S.</given-names></name><name><surname>Zhong</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Sweitzer</surname><given-names>S.</given-names></name><etal></etal></person-group>
<article-title>SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-kappaB activity</article-title>
<source>PLoS ONE</source>
<year>2012</year>
<volume>7</volume>
<elocation-id>e46364</elocation-id>
<pub-id pub-id-type="pmid">23029496</pub-id></element-citation></ref><ref id="B68-nutrients-09-00116"><label>68.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elton</surname><given-names>L.</given-names></name><name><surname>Carpentier</surname><given-names>I.</given-names></name><name><surname>Staal</surname><given-names>J.</given-names></name><name><surname>Driege</surname><given-names>Y.</given-names></name><name><surname>Haegman</surname><given-names>M.</given-names></name><name><surname>Beyaert</surname><given-names>R.</given-names></name></person-group>
<article-title>MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-kappaB signaling</article-title>
<source>FEBS J.</source>
<year>2016</year>
<volume>283</volume>
<fpage>403</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1111/febs.13597</pub-id>
<pub-id pub-id-type="pmid">26573773</pub-id></element-citation></ref><ref id="B69-nutrients-09-00116"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ba</surname><given-names>X.</given-names></name><name><surname>Garg</surname><given-names>N.J.</given-names></name></person-group>
<article-title>Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases</article-title>
<source>Am. J. Pathol.</source>
<year>2011</year>
<volume>178</volume>
<fpage>946</fpage>
<lpage>955</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2010.12.004</pub-id>
<pub-id pub-id-type="pmid">21356345</pub-id></element-citation></ref><ref id="B70-nutrients-09-00116"><label>70.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Piret</surname><given-names>B.</given-names></name><name><surname>Schoonbroodt</surname><given-names>S.</given-names></name><name><surname>Piette</surname><given-names>J.</given-names></name></person-group>
<article-title>The ATM protein is required for sustained activation of NF-kappaB following DNA damage</article-title>
<source>Oncogene</source>
<year>1999</year>
<volume>18</volume>
<fpage>2261</fpage>
<lpage>2271</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1202541</pub-id>
<pub-id pub-id-type="pmid">10327072</pub-id></element-citation></ref><ref id="B71-nutrients-09-00116"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Macrae</surname><given-names>K.</given-names></name><name><surname>Stretton</surname><given-names>C.</given-names></name><name><surname>Lipina</surname><given-names>C.</given-names></name><name><surname>Blachnio-Zabielska</surname><given-names>A.</given-names></name><name><surname>Baranowski</surname><given-names>M.</given-names></name><name><surname>Gorski</surname><given-names>J.</given-names></name><name><surname>Marley</surname><given-names>A.</given-names></name><name><surname>Hundal</surname><given-names>H.S.</given-names></name></person-group>
<article-title>Defining the role of DAG, mitochondrial function, and lipid deposition in palmitate-induced proinflammatory signaling and its counter-modulation by palmitoleate</article-title>
<source>J. Lipid Res.</source>
<year>2013</year>
<volume>54</volume>
<fpage>2366</fpage>
<lpage>2378</lpage>
<pub-id pub-id-type="doi">10.1194/jlr.M036996</pub-id>
<pub-id pub-id-type="pmid">23833248</pub-id></element-citation></ref><ref id="B72-nutrients-09-00116"><label>72.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Zamel</surname><given-names>R.</given-names></name><name><surname>Bai</surname><given-names>X.-H.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name></person-group>
<article-title>PKC Activation Induces Inflammatory Response and Cell Death in Human Bronchial Epithelial Cells</article-title>
<source>PLoS ONE</source>
<year>2013</year>
<volume>8</volume>
<elocation-id>e64182</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0064182</pub-id>
<pub-id pub-id-type="pmid">23691166</pub-id></element-citation></ref><ref id="B73-nutrients-09-00116"><label>73.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hellmann</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>M.J.</given-names></name><name><surname>Hai</surname><given-names>T.</given-names></name><name><surname>Bhatnagar</surname><given-names>A.</given-names></name><name><surname>Srivastava</surname><given-names>S.</given-names></name><name><surname>Spite</surname><given-names>M.</given-names></name></person-group>
<article-title>Atf3 negatively regulates Ptgs2/Cox2 expression during acute inflammation</article-title>
<source>Prostaglandins Other Lipid Mediat.</source>
<year>2015</year>
<volume>116–117</volume>
<fpage>49</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/j.prostaglandins.2015.01.001</pub-id>
<pub-id pub-id-type="pmid">25619459</pub-id></element-citation></ref><ref id="B74-nutrients-09-00116"><label>74.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Badrichani</surname><given-names>A.Z.</given-names></name><name><surname>Stroka</surname><given-names>D.M.</given-names></name><name><surname>Bilbao</surname><given-names>G.</given-names></name><name><surname>Curiel</surname><given-names>D.T.</given-names></name><name><surname>Bach</surname><given-names>F.H.</given-names></name><name><surname>Ferran</surname><given-names>C.</given-names></name></person-group>
<article-title>Bcl-2 and Bcl-X(L) serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB</article-title>
<source>J. Clin. Investig.</source>
<year>1999</year>
<volume>103</volume>
<fpage>543</fpage>
<lpage>553</lpage>
<pub-id pub-id-type="doi">10.1172/JCI2517</pub-id>
<pub-id pub-id-type="pmid">10021463</pub-id></element-citation></ref><ref id="B75-nutrients-09-00116"><label>75.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zehavi</surname><given-names>L.</given-names></name><name><surname>Schayek</surname><given-names>H.</given-names></name><name><surname>Jacob-Hirsch</surname><given-names>J.</given-names></name><name><surname>Sidi</surname><given-names>Y.</given-names></name><name><surname>Leibowitz-Amit</surname><given-names>R.</given-names></name><name><surname>Avni</surname><given-names>D.</given-names></name></person-group>
<article-title>MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma</article-title>
<source>Mol. Cancer</source>
<year>2015</year>
<volume>14</volume>
<fpage>68</fpage>
<pub-id pub-id-type="doi">10.1186/s12943-015-0338-9</pub-id>
<pub-id pub-id-type="pmid">25889255</pub-id></element-citation></ref><ref id="B76-nutrients-09-00116"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guijarro-Munoz</surname><given-names>I.</given-names></name><name><surname>Compte</surname><given-names>M.</given-names></name><name><surname>Alvarez-Cienfuegos</surname><given-names>A.</given-names></name><name><surname>Alvarez-Vallina</surname><given-names>L.</given-names></name><name><surname>Sanz</surname><given-names>L.</given-names></name></person-group>
<article-title>Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-kappaB signaling pathway and proinflammatory response in human pericytes</article-title>
<source>J. Biol. Chem.</source>
<year>2014</year>
<volume>289</volume>
<fpage>2457</fpage>
<lpage>2468</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M113.521161</pub-id>
<pub-id pub-id-type="pmid">24307174</pub-id></element-citation></ref><ref id="B77-nutrients-09-00116"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>G.L.</given-names></name><name><surname>Bao</surname><given-names>J.F.</given-names></name><name><surname>Yu</surname><given-names>Q.</given-names></name></person-group>
<article-title>Let-7 miRNAs Modulate the Activation of NF-kappaB by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis</article-title>
<source>PLoS ONE</source>
<year>2015</year>
<volume>10</volume>
<elocation-id>e0121256</elocation-id>
<pub-id pub-id-type="pmid">26110642</pub-id></element-citation></ref><ref id="B78-nutrients-09-00116"><label>78.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wullaert</surname><given-names>A.</given-names></name><name><surname>Heyninck</surname><given-names>K.</given-names></name><name><surname>Janssens</surname><given-names>S.</given-names></name><name><surname>Beyaert</surname><given-names>R.</given-names></name></person-group>
<article-title>Ubiquitin: Tool and target for intracellular NF-kappaB inhibitors</article-title>
<source>Trends Immunol.</source>
<year>2006</year>
<volume>27</volume>
<fpage>533</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2006.09.003</pub-id>
<pub-id pub-id-type="pmid">16982211</pub-id></element-citation></ref><ref id="B79-nutrients-09-00116"><label>79.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Teng</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>L.G.</given-names></name><name><surname>Zhai</surname><given-names>Z.</given-names></name><name><surname>Shu</surname><given-names>H.B.</given-names></name></person-group>
<article-title>ZNF216 Is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation</article-title>
<source>J. Biol. Chem.</source>
<year>2004</year>
<volume>279</volume>
<fpage>16847</fpage>
<lpage>16853</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M309491200</pub-id>
<pub-id pub-id-type="pmid">14754897</pub-id></element-citation></ref><ref id="B80-nutrients-09-00116"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sears</surname><given-names>D.D.</given-names></name><name><surname>Hsiao</surname><given-names>G.</given-names></name><name><surname>Hsiao</surname><given-names>A.</given-names></name><name><surname>Yu</surname><given-names>J.G.</given-names></name><name><surname>Courtney</surname><given-names>C.H.</given-names></name><name><surname>Ofrecio</surname><given-names>J.M.</given-names></name><name><surname>Chapman</surname><given-names>J.</given-names></name><name><surname>Subramaniam</surname><given-names>S.</given-names></name></person-group>
<article-title>Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2009</year>
<volume>106</volume>
<fpage>18745</fpage>
<lpage>18750</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0903032106</pub-id>
<pub-id pub-id-type="pmid">19841271</pub-id></element-citation></ref><ref id="B81-nutrients-09-00116"><label>81.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valverde</surname><given-names>A.M.</given-names></name><name><surname>Burks</surname><given-names>D.J.</given-names></name><name><surname>Fabregat</surname><given-names>I.</given-names></name><name><surname>Fisher</surname><given-names>T.L.</given-names></name><name><surname>Carretero</surname><given-names>J.</given-names></name><name><surname>White</surname><given-names>M.F.</given-names></name><name><surname>Benito</surname><given-names>M.</given-names></name></person-group>
<article-title>Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes</article-title>
<source>Diabetes</source>
<year>2003</year>
<volume>52</volume>
<fpage>2239</fpage>
<lpage>2248</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.52.9.2239</pub-id>
<pub-id pub-id-type="pmid">12941762</pub-id></element-citation></ref><ref id="B82-nutrients-09-00116"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>F.</given-names></name><name><surname>Lindh</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Ruishalme</surname><given-names>I.</given-names></name><name><surname>ÖSt</surname><given-names>A.</given-names></name><name><surname>Sahachartsiri</surname><given-names>B.</given-names></name><name><surname>StrÅLfors</surname><given-names>P.</given-names></name><name><surname>Degerman</surname><given-names>E.</given-names></name><name><surname>Manganiello</surname><given-names>V.C.</given-names></name></person-group>
<article-title>Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the β(3)-adrenergic receptor agonist CL316243: Effects of caveolin-1 knockdown on formation/maintenance of macromolecular signalling complexes</article-title>
<source>Biochem. J.</source>
<year>2009</year>
<volume>424</volume>
<fpage>399</fpage>
<lpage>410</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20090842</pub-id>
<pub-id pub-id-type="pmid">19747167</pub-id></element-citation></ref><ref id="B83-nutrients-09-00116"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terashima</surname><given-names>M.</given-names></name><name><surname>Fujita</surname><given-names>Y.</given-names></name><name><surname>Togashi</surname><given-names>Y.</given-names></name><name><surname>Sakai</surname><given-names>K.</given-names></name><name><surname>De Velasco</surname><given-names>M.A.</given-names></name><name><surname>Tomida</surname><given-names>S.</given-names></name><name><surname>Nishio</surname><given-names>K.</given-names></name></person-group>
<article-title>KIAA1199 interacts with glycogen phosphorylase kinase beta-subunit (PHKB) to promote glycogen breakdown and cancer cell survival</article-title>
<source>Oncotarget</source>
<year>2014</year>
<volume>5</volume>
<fpage>7040</fpage>
<lpage>7050</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.2220</pub-id>
<pub-id pub-id-type="pmid">25051373</pub-id></element-citation></ref><ref id="B84-nutrients-09-00116"><label>84.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B.L.</given-names></name><name><surname>Xu</surname><given-names>R.L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>X.X.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>L.P.</given-names></name><name><surname>Hu</surname><given-names>J.Q.</given-names></name><name><surname>Zhang</surname><given-names>J.L.</given-names></name><name><surname>Ye</surname><given-names>Z.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><etal></etal></person-group>
<article-title>Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway</article-title>
<source>J. Cardiol.</source>
<year>2013</year>
<volume>62</volume>
<fpage>241</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1016/j.jjcc.2013.04.010</pub-id>
<pub-id pub-id-type="pmid">23778007</pub-id></element-citation></ref><ref id="B85-nutrients-09-00116"><label>85.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galic</surname><given-names>S.</given-names></name><name><surname>Hauser</surname><given-names>C.</given-names></name><name><surname>Kahn</surname><given-names>B.B.</given-names></name><name><surname>Haj</surname><given-names>F.G.</given-names></name><name><surname>Neel</surname><given-names>B.G.</given-names></name><name><surname>Tonks</surname><given-names>N.K.</given-names></name><name><surname>Tiganis</surname><given-names>T.</given-names></name></person-group>
<article-title>Coordinated Regulation of Insulin Signaling by the Protein Tyrosine Phosphatases PTP1B and TCPTP</article-title>
<source>Mol. Cell. Biol.</source>
<year>2005</year>
<volume>25</volume>
<fpage>819</fpage>
<lpage>829</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.25.2.819-829.2005</pub-id>
<pub-id pub-id-type="pmid">15632081</pub-id></element-citation></ref><ref id="B86-nutrients-09-00116"><label>86.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saucedo</surname><given-names>L.J.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Chiarelli</surname><given-names>D.A.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Pan</surname><given-names>D.</given-names></name><name><surname>Edgar</surname><given-names>B.A.</given-names></name></person-group>
<article-title>Rheb promotes cell growth as a component of the insulin/TOR signalling network</article-title>
<source>Nat. Cell Biol.</source>
<year>2003</year>
<volume>5</volume>
<fpage>566</fpage>
<lpage>571</lpage>
<pub-id pub-id-type="doi">10.1038/ncb996</pub-id>
<pub-id pub-id-type="pmid">12766776</pub-id></element-citation></ref><ref id="B87-nutrients-09-00116"><label>87.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Hamm</surname><given-names>L.</given-names></name><name><surname>Batuman</surname><given-names>V.</given-names></name><name><surname>Whelton</surname><given-names>P.K.</given-names></name></person-group>
<article-title>Serum antioxidant vitamins and blood pressure in the United States population</article-title>
<source>Hypertension</source>
<year>2002</year>
<volume>40</volume>
<fpage>810</fpage>
<lpage>816</lpage>
<pub-id pub-id-type="doi">10.1161/01.HYP.0000039962.68332.59</pub-id>
<pub-id pub-id-type="pmid">12468562</pub-id></element-citation></ref><ref id="B88-nutrients-09-00116"><label>88.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>John</surname><given-names>J.H.</given-names></name><name><surname>Ziebland</surname><given-names>S.</given-names></name><name><surname>Yudkin</surname><given-names>P.</given-names></name><name><surname>Roe</surname><given-names>L.S.</given-names></name><name><surname>Neil</surname><given-names>H.A.W.</given-names></name></person-group>
<article-title>Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: A randomised controlled trial</article-title>
<source>Lancet</source>
<year>2002</year>
<volume>359</volume>
<fpage>1969</fpage>
<lpage>1974</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(02)98858-6</pub-id>
<pub-id pub-id-type="pmid">12076551</pub-id></element-citation></ref><ref id="B89-nutrients-09-00116"><label>89.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pickering</surname><given-names>T.</given-names></name></person-group>
<article-title>Blood pressure measurement and detection of hypertension</article-title>
<source>Lancet</source>
<year>1994</year>
<volume>344</volume>
<fpage>31</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(94)91053-7</pub-id>
<pub-id pub-id-type="pmid">7912303</pub-id></element-citation></ref><ref id="B90-nutrients-09-00116"><label>90.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sevenoaks</surname><given-names>M.J.</given-names></name><name><surname>Stockley</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Chronic obstructive pulmonary disease, inflammation and co-morbidity—A common inflammatory phenotype</article-title>
<source>Respir. Res.</source>
<year>2006</year>
<volume>7</volume>
<fpage>70</fpage>
<pub-id pub-id-type="doi">10.1186/1465-9921-7-70</pub-id>
<pub-id pub-id-type="pmid">16669999</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-09-00116-f001" position="float"><label>Figure 1</label><caption><p>Patient flow consolidated standards of reporting trials (CONSORT) diagram. A total of 395 patients were screened for eligibility to participate; 61 of those who were eligible and wished to participate were randomised to either the fruit and vegetable juice concentrate intervention group or placebo, each taking three capsules twice daily.</p></caption><graphic xlink:href="nutrients-09-00116-g001"></graphic></fig><fig id="nutrients-09-00116-f002" position="float"><label>Figure 2</label><caption><p>Validation of microarray analysis; fold changes in gene expression following the intervention as determined by microarray versus quantitative polymerase chain reaction (qPCR). Zinc finger, AN1-type domain 5 (ZFAND5); Phosphomevalonate kinase (PMVK).</p></caption><graphic xlink:href="nutrients-09-00116-g002"></graphic></fig><fig id="nutrients-09-00116-f003" position="float"><label>Figure 3</label><caption><p>Change in peripheral blood mRNA expression of PMVK (<bold>A</bold>) and ZFAND5 (<bold>B</bold>) at baseline compared to Week 8 in the fruit and vegetable juice concentrate (F&amp;V concentrate) and placebo groups; measured using qPCR; the data presented are the median (IQR); the statistical test used was the Mann–Whitney test; * <italic>p</italic> &lt; 0.05 versus baseline.</p></caption><graphic xlink:href="nutrients-09-00116-g003"></graphic></fig><table-wrap id="nutrients-09-00116-t001" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t001_Table 1</object-id><label>Table 1</label><caption><p>Baseline subject demographics and nutrient intake. F&amp;V, fruit and vegetables.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">F&amp;V Concentrate (<italic>n</italic> = 28)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Placebo (<italic>n</italic> = 28)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>Demographics</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Gender (male/female)</td><td align="center" valign="middle" rowspan="1" colspan="1">11/17</td><td align="center" valign="middle" rowspan="1" colspan="1">13/15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.788</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Age (years) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">61.4 ± 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">57.9 ± 1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.091</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  BMI (kg/m<sup>2</sup>) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">34.6 ± 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">37.0 ± 1.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.271</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Smoking Status (never/ex)</td><td align="center" valign="middle" rowspan="1" colspan="1">14/14</td><td align="center" valign="middle" rowspan="1" colspan="1">16/12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.592</td></tr><tr><td colspan="4" align="left" valign="middle" rowspan="1"><bold>Nutrient Intake</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Total Energy (KJ/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7785 (6145, 10,371)</td><td align="center" valign="middle" rowspan="1" colspan="1">6986 (5573, 8448)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.110</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Total fat (g/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">78 (63, 107)</td><td align="center" valign="middle" rowspan="1" colspan="1">70 (59, 87)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.229</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">   SFA (g/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">32 (25, 45)</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (24, 37)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.205</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">   PUFA (g/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12 ± 1</td><td align="center" valign="middle" rowspan="1" colspan="1">12 ± 1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.626</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">   MUFA (g/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">31 ± 2</td><td align="center" valign="middle" rowspan="1" colspan="1">28 ± 2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.286</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Protein (g/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">101 ± 7</td><td align="center" valign="middle" rowspan="1" colspan="1">77 (73, 99)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.103</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Carbohydrates (g/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">202 ± 15</td><td align="center" valign="middle" rowspan="1" colspan="1">177 ± 11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.169</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Fibre (g/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">23 ± 2</td><td align="center" valign="middle" rowspan="1" colspan="1">21 ± 1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.285</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Calcium (mg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">965 ± 50</td><td align="center" valign="middle" rowspan="1" colspan="1">857 ± 50</td><td align="center" valign="middle" rowspan="1" colspan="1">0.134</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Folate (µg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">342 ± 17</td><td align="center" valign="middle" rowspan="1" colspan="1">238 ± 14</td><td align="center" valign="middle" rowspan="1" colspan="1">0.046</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Iron (mg/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">14 (10, 21)</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (9, 14)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.103</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Magnesium (mg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">319 ± 21</td><td align="center" valign="middle" rowspan="1" colspan="1">270 ± 14</td><td align="center" valign="middle" rowspan="1" colspan="1">0.060</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Niacin (mg/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">22 (17, 29)</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (14, 25)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.126</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Phosphorus (mg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1732 ± 118</td><td align="center" valign="middle" rowspan="1" colspan="1">1459 ± 77</td><td align="center" valign="middle" rowspan="1" colspan="1">0.058</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Potassium (mg/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3078 (2312, 3534)</td><td align="center" valign="middle" rowspan="1" colspan="1">2409 (2065, 3014)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.051</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Retinol (µg/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">351 (303, 443)</td><td align="center" valign="middle" rowspan="1" colspan="1">340 (277, 435)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.651</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Riboflavin (mg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3 ± 0</td><td align="center" valign="middle" rowspan="1" colspan="1">2 ± 0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.055</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Sodium (mg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2647 ± 197</td><td align="center" valign="middle" rowspan="1" colspan="1">2476 ± 158</td><td align="center" valign="middle" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Thiamine (mg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2 ± 0</td><td align="center" valign="middle" rowspan="1" colspan="1">1 ± 0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.064</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Vitamin C (mg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">105 ± 11</td><td align="center" valign="middle" rowspan="1" colspan="1">95 ± 8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.417</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Vitamin E (mg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7 ± 1</td><td align="center" valign="middle" rowspan="1" colspan="1">6 ± 0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.273</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Zinc (mg/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">13 (9, 18)</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (9, 12)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.114</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  α-carotene (µg/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">811 (416, 1244)</td><td align="center" valign="middle" rowspan="1" colspan="1">643 (324, 830)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.122</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  β-carotene (µg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4068 ± 387</td><td align="center" valign="middle" rowspan="1" colspan="1">3255 ± 273</td><td align="center" valign="middle" rowspan="1" colspan="1">0.092</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  β-cryptoxanthin (µg/day) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">125 (48, 284)</td><td align="center" valign="middle" rowspan="1" colspan="1">169 (85, 234)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.675</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">  Lutein/zeaxanthin (µg/day) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">862 ± 78</td><td align="center" valign="middle" rowspan="1" colspan="1">723 ± 65</td><td align="center" valign="middle" rowspan="1" colspan="1">0.177</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Lycopene (µg/day) <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3967 (2602, 6338)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3807 (2324, 7564)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.950</td></tr></tbody></table><table-wrap-foot><fn><p>BMI: body mass index; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; <sup>a</sup> mean ± standard error of the mean (SEM); <sup>b</sup> median (Q1, Q3).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00116-t002" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t002_Table 2</object-id><label>Table 2</label><caption><p>Fruit and vegetable intake, plasma carotenoids and plasma α-tocopherol before and after the intervention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">F&amp;V Concentrate (<italic>n</italic> = 28)</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Placebo (<italic>n</italic> = 28)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ANCOVA <sup>ǂ</sup>
<italic>p</italic>-Value</th></tr></thead><tbody><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><bold>Fruit and Vegetable Intake (Servings/Day)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Fruit <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 <break></break>(0.00, 1.88)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.75 <break></break>(0.00, 1.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.517</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 <break></break>(0.00, 1.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.50 <break></break>(0.00, 1.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.149</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.222</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Vegetables <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.45 ± 0.19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.52 ± 0.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.784</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.34 ± 0.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.46 ±. 023</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.683</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.945</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Total <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.38 ± 0.21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.30 ± 0.16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.788</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.14 ± 0.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.00 ± 0.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.665</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.383</td></tr><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><bold>Plasma Carotenoids (mg/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Lutein <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.43 <break></break>(0.36, 0.52)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.45 <break></break>(0.34, 0.59)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.545</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.37 <break></break>(0.30, 0.52)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.37 <break></break>(0.28, 0.49)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.922</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.127</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> β-cryptoxanthin <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.09 <break></break>(0.05, 0.15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07 <break></break>(0.05, 0.12)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.375</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07 <break></break>(0.04, 0.16)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.06 <break></break>(0.03, 0.13)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.269</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Lycopene <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.10 <break></break>(0.08, 0.14)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 <break></break>(0.08, 0.18)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.213</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.11 <break></break>(0.07, 0.17)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.08 <break></break>(0.04, 0.11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> α-carotene <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 <break></break>(0.00, 0.15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 <break></break>(0.00, 0.01)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.188</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 <break></break>(0.00, 0.02)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 <break></break>(0.00, 0.01)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.095</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> β-carotene <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.11 <break></break>(0.07, 0.15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.16 <break></break>(0.11, 0.26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07 <break></break>(0.00, 0.16)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.06 <break></break>(0.00, 0.11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Total Carotenoids <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.73 <break></break>(0.60, 1.05)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.85 <break></break>(0.76, 0.99)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72 <break></break>(0.51, 1.01)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.59 <break></break>(0.49, 0.80)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Plasma α-Tocopherol (mg/L) <sup>b</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.6 <break></break>(11.3, 15.9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.2 <break></break>(12.1, 15.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.849</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.3 <break></break>(11.3, 25.6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.4 <break></break>(11.6, 17.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.360</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.568</td></tr></tbody></table><table-wrap-foot><fn><p>* The <italic>p</italic>-value refers to the change between baseline and eight weeks within each group; <sup>ǂ</sup> analysis of covariance (ANCOVA) was used to compare the change in the F&amp;V concentrate group to the change in the placebo group; <sup>a</sup> mean ± standard error of the mean (SEM); <sup>b</sup> median (Q1, Q3).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00116-t003" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t003_Table 3</object-id><label>Table 3</label><caption><p>Lipid profiles, glycated haemoglobin and systemic inflammation before and after the intervention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">F&amp;V Concentrate (<italic>n</italic> = 28)</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Placebo (<italic>n</italic> = 28)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ANCOVA <sup>ǂ</sup>
<break></break><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Total Cholesterol (mmol/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.70 <break></break>(5.00, 6.30)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.50 <break></break>(4.83, 6.15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.90 <break></break>(4.50, 6.70)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.60 <break></break>(4.60, 6.20)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.532</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.359</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>LDL Cholesterol (mmol/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.63 <break></break>(3.17, 4.36)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.50 <break></break>(2.95, 4.27)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.032</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.15 <break></break>(3.03, 4.63)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.51 <break></break>(2.89, 4.10)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.089</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.904</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>HDL Cholesterol (mmol/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.20 <break></break>(1.10, 1.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.20 <break></break>(1.10, 1.30)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.815</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.20 <break></break>(1.00, 1.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.20 <break></break>(1.00, 1.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.941</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.308</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Total/HDL Cholesterol</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.50 <break></break>(4.00, 5.10)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.55 <break></break>(4.05, 5.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.221</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.60 <break></break>(3.90, 5.60)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.60 <break></break>(3.90, 5.50)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.587</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.634</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Triglycerides (mmol/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.24 <break></break>(0.86, 1.81)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.23 <break></break>(1.01, 1.67)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.344</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.36 <break></break>(0.97, 1.83)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.53 <break></break>(1.06, 1.84)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.022</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>HbA1c (%)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.40 <break></break>(5.20, 5.60)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.30 <break></break>(5.10, 5.50)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.570</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.40 <break></break>(5.20, 5.70)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.30 <break></break>(5.10, 5.50)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.149</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.407</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>TNFα (pg/mL)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04 <break></break>(0.87, 1.41)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.02 <break></break>(0.55, 1.41)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.037</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07 <break></break>(0.79, 1.22)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.94 <break></break>(0.82, 1.26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.797</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.071</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>sTNFR1 (pg/mL)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1140 <break></break>(1017, 1382)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1108 <break></break>(992, 1335)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.829</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1120 <break></break>(967, 1319)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1147 <break></break>(953, 1383)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.378</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.668</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>sTNFR2 (pg/mL)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2479 <break></break>(2257, 3034)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2345 <break></break>(2209, 3130)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.467</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2332 <break></break>(1986, 2677)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2547 <break></break>(2047, 2754)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.299</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Ox-LDL (mU/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48,620 <break></break>(41,249, 62,976)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48,352 <break></break>(41,937, 57,960)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.990</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50,053 <break></break>(41,262, 64,661)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48,911 <break></break>(43,400, 59,733)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.551</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.781</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>CRP (mg/mL)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.1 <break></break>(1.7, 5.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.9 <break></break>(1.2, 5.9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.536</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.2 <break></break>(1.7, 5.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5 <break></break>(1.5, 5.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.769</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.301</td></tr></tbody></table><table-wrap-foot><fn><p>* The <italic>p</italic>-value refers to the change between baseline and eight weeks within each group; <sup>ǂ</sup> ANCOVA was used to compare the change in the F&amp;V concentrate group to the change in the placebo group; all data are presented as the median (Q1, Q3). Low-density lipoprotein (LDL); high-density lipoprotein (HDL); haemoglobin A1c (HbA1c); tumour necrosis factor (TNF) α; soluble TNF receptor 1 (sTNFR1); soluble TNF receptor 2 (sTNFR2); oxidized-LDL (ox-LDL); C-reactive protein (CRP).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00116-t004" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t004_Table 4</object-id><label>Table 4</label><caption><p>Body composition, blood pressure and quality of life before and after the intervention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">F&amp;V Concentrate (<italic>n</italic> = 28)</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Placebo (<italic>n</italic> =28)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ANCOVA <sup>ǂ</sup>
<break></break><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>BMI (kg/m<sup>2</sup>) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.6 ± 0.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.6 ± 0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.076</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.0 ± 1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.1 ± 1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.781</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.336</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Waist circumference (cm) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">113.7 ± 2.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">112.5 ± 2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.649</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">116.6 ± 2.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">116.0 ± 2.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.863</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.699</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Body Composition</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Total Body Fat (kg) <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42.6 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42.7 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.728</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.1 ± 2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.8 ± 2.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.231</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.618</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> % Body Fat <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.7 ± 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.4 ± 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.168</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.0 ± 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.4 ± 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.384</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.134</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Total Lean Mass (kg) <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.3 ± 2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.0 ± 2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.4 ± 2.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.0 ± 2.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.836</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.057</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> % Lean Mass <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.4 ± 1.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.9 ± 1.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.078</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.5 ± 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.0 ± 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.560</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.096</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Android: Gynoid Fat Ratio <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2 ± 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2 ± 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.499</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 ± 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 ± 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.649</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Systolic BP (mmHg) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">131.7 ± 2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125.9 ± 1.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">136.7 ± 2.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">132.4 ± 2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.037</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.110</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Diastolic BP (mmHg) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.6 ± 1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.0 ± 1.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.097</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.6 ± 1.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.3 ± 1.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.665</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.055</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Pulse (BPM) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.1 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.6 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.175</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.8 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.4 ± 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.709</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.178</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Quality of Life (SF-36)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Physical <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.2 ± 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.8 ± 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.788</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.6 ± 1.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.2 ± 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.678</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.682</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Mental <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.6 <break></break>(43.6, 58.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.1 <break></break>(48.3, 59.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.211</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.4 <break></break>(40.1, 59.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.0 <break></break>(45.3, 58.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.897</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.290</td></tr></tbody></table><table-wrap-foot><fn><p>BMI: body mass index; BP: blood pressure; * the <italic>p</italic>-value refers to the change between baseline and eight weeks within each group; <sup>ǂ</sup> ANCOVA was used to compare the change in the F&amp;V concentrate group to the change in the placebo group; <sup>a</sup> mean ± SEM; <sup>b</sup> median (Q1, Q3). 36 item short form health survey (SF-36).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00116-t005" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t005_Table 5</object-id><label>Table 5</label><caption><p>Baseline subject demographics and nutrient intake of subjects with high baseline CRP (≥3.0 mg/mL).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">F&amp;V Concentrate (<italic>n</italic> = 16)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Placebo (<italic>n</italic> = 15)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Demographics</bold></td><td align="center" valign="top" rowspan="1" colspan="1">
</td><td align="center" valign="top" rowspan="1" colspan="1">
</td><td align="center" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Gender (male/female)</td><td align="center" valign="top" rowspan="1" colspan="1">3/13</td><td align="center" valign="top" rowspan="1" colspan="1">6/9</td><td align="center" valign="top" rowspan="1" colspan="1">0.252</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  BMI (kg/m<sup>2</sup>) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">35.6 ± 1.1</td><td align="center" valign="top" rowspan="1" colspan="1">40.2 ± 1.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.016</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Age (years) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">60.8 ± 1.5</td><td align="center" valign="top" rowspan="1" colspan="1">56.6 ± 2.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.097</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Smoking Status (never/ex)</td><td align="center" valign="top" rowspan="1" colspan="1">9/8</td><td align="center" valign="top" rowspan="1" colspan="1">8/7</td><td align="center" valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Nutrient Intake</bold></td><td align="center" valign="top" rowspan="1" colspan="1">
</td><td align="center" valign="top" rowspan="1" colspan="1">
</td><td align="center" valign="top" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Total Energy (KJ/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">7884 ± 792</td><td align="center" valign="top" rowspan="1" colspan="1">7569 ± 625</td><td align="center" valign="top" rowspan="1" colspan="1">0.758</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Total fat (g/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">83 ± 9</td><td align="center" valign="top" rowspan="1" colspan="1">81 ± 7</td><td align="center" valign="top" rowspan="1" colspan="1">0.857</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">   SFA (g/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">30 (24, 45)</td><td align="center" valign="top" rowspan="1" colspan="1">28 (24, 43)</td><td align="center" valign="top" rowspan="1" colspan="1">0.688</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">   PUFA (g/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">11 ± 1</td><td align="center" valign="top" rowspan="1" colspan="1">12 ± 1</td><td align="center" valign="top" rowspan="1" colspan="1">0.609</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">   MUFA (g/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">30 ± 3</td><td align="center" valign="top" rowspan="1" colspan="1">30 ± 3</td><td align="center" valign="top" rowspan="1" colspan="1">&gt;0.999</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Protein (g/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">94 (67, 120)</td><td align="center" valign="top" rowspan="1" colspan="1">77 (73, 110)</td><td align="center" valign="top" rowspan="1" colspan="1">0.858</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Carbohydrates (g/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">190 ± 20</td><td align="center" valign="top" rowspan="1" colspan="1">181 ± 16</td><td align="center" valign="top" rowspan="1" colspan="1">0.738</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Fibre (g/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">22 ± 2</td><td align="center" valign="top" rowspan="1" colspan="1">20 ± 2</td><td align="center" valign="top" rowspan="1" colspan="1">0.429</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Calcium (mg/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">926 ± 64</td><td align="center" valign="top" rowspan="1" colspan="1">871 ± 67</td><td align="center" valign="top" rowspan="1" colspan="1">0.559</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Folate (<bold>µ</bold>g/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">267 (194, 329)</td><td align="center" valign="top" rowspan="1" colspan="1">213 (189, 294)</td><td align="center" valign="top" rowspan="1" colspan="1">0.418</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Iron (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">12 (9, 20)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (9, 14)</td><td align="center" valign="top" rowspan="1" colspan="1">0.509</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Magnesium (mg/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">312 ± 31</td><td align="center" valign="top" rowspan="1" colspan="1">271 ± 20</td><td align="center" valign="top" rowspan="1" colspan="1">0.271</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Niacin (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">20 (14, 25)</td><td align="center" valign="top" rowspan="1" colspan="1">18 (14, 26)</td><td align="center" valign="top" rowspan="1" colspan="1">0.800</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Phosphorus (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">1500 (1250, 2002)</td><td align="center" valign="top" rowspan="1" colspan="1">1357 (1140, 1859)</td><td align="center" valign="top" rowspan="1" colspan="1">0.377</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Potassium (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">2847 (2090, 3609)</td><td align="center" valign="top" rowspan="1" colspan="1">2501 (2081, 2896)</td><td align="center" valign="top" rowspan="1" colspan="1">0.533</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Retinol (<bold>µ</bold>g/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">342 (254, 507)</td><td align="center" valign="top" rowspan="1" colspan="1">376 (311, 473)</td><td align="center" valign="top" rowspan="1" colspan="1">0.688</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Riboflavin (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">2 (2, 3)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (2, 3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.397</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Sodium (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">2177 (1797, 2738)</td><td align="center" valign="top" rowspan="1" colspan="1">2286 (1845, 3623)</td><td align="center" valign="top" rowspan="1" colspan="1">0.463</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Thiamine (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">2 (1, 2)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1, 2)</td><td align="center" valign="top" rowspan="1" colspan="1">0.558</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Vitamin C (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">88 (63, 111)</td><td align="center" valign="top" rowspan="1" colspan="1">90 (57, 111)</td><td align="center" valign="top" rowspan="1" colspan="1">0.883</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Vitamin E (mg/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">7 ± 1</td><td align="center" valign="top" rowspan="1" colspan="1">6 ± 1</td><td align="center" valign="top" rowspan="1" colspan="1">0.702</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Zinc (mg/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">13 (8, 16)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (9, 14)</td><td align="center" valign="top" rowspan="1" colspan="1">0.716</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  α-Carotene (<bold>µ</bold>g/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">916 ± 128</td><td align="center" valign="top" rowspan="1" colspan="1">684 ± 121</td><td align="center" valign="top" rowspan="1" colspan="1">0.198</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  β-Carotene (<bold>µ</bold>g/day) <sup>a</sup></td><td align="center" valign="top" rowspan="1" colspan="1">351 ± 36</td><td align="center" valign="top" rowspan="1" colspan="1">3350 ± 412</td><td align="center" valign="top" rowspan="1" colspan="1">0.352</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  β-Cryptoxanthin (<bold>µ</bold>g/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">105 (48, 193)</td><td align="center" valign="top" rowspan="1" colspan="1">164 (89, 225)</td><td align="center" valign="top" rowspan="1" colspan="1">0.222</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">  Lutein/zeaxanthin (<bold>µ</bold>g/day) <sup>b</sup></td><td align="center" valign="top" rowspan="1" colspan="1">803 (584, 903)</td><td align="center" valign="top" rowspan="1" colspan="1">744 (332, 1134)</td><td align="center" valign="top" rowspan="1" colspan="1">0.509</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">  Lycopene (<bold>µ</bold>g/day) <sup>b</sup></td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">3523 (2409, 4931)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">2829 (2040, 9169)</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">0.887</td></tr></tbody></table><table-wrap-foot><fn><p>BMI: body mass index; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; <sup>a</sup> mean ± SEM; <sup>b</sup> median (Q1, Q3).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00116-t006" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t006_Table 6</object-id><label>Table 6</label><caption><p>Fruit and vegetable intake, plasma carotenoids and plasma α-tocopherol before and after the intervention in subjects with high baseline CRP (≥3.0 mg/mL).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">F&amp;V Concentrate (<italic>n</italic> = 16)</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Placebo (<italic>n</italic> = 15)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ANCOVA <sup>ǂ</sup><break></break><italic>p</italic>-Value</th></tr></thead><tbody><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><bold>Fruit and Vegetable Intake (Servings/Day)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Fruit <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 <break></break>(0.00, 1.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.75 <break></break>(0.00, 2.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.899</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.75 <break></break>(0.00, 1.38)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.50 <break></break>(0.00, 1.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.475</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.283</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Vegetables <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.25 <break></break>(0.63, 2.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.75 <break></break>(1.00, 2.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.606</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 <break></break>(0.13, 1.88)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 <break></break>(0.50, 2.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.435</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.893</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Total <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.13 ± 0.26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.38 ± 0.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.478</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.78 ± 0.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.00 ± 0.32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.596</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.475</td></tr><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><bold>Plasma Carotenoids (mg/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Lutein <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.41 <break></break>(0.37, 0.47)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.45 <break></break>(0.33, 0.55)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.519</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.36 <break></break>(0.29, 0.42)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.35 <break></break>(0.28, 0.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.855</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.204</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  β-cryptoxanthin <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.08 <break></break>(0.05, 0.13)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07 <break></break>(0.05, 0.12)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.900</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07 <break></break>(0.02, 0.13)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.06 <break></break>(0.02, 0.13)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.500</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.491</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Lycopene <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.10 <break></break>(0.08, 0.15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 <break></break>(0.08, 0.14)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.850</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.11 <break></break>(0.09, 0.19)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.10 <break></break>(0.03, 0.12)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.026</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  α-carotene <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 <break></break>(0.00, 0.02)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 <break></break>(0.00, 0.01)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.148</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 <break></break>(0.00, 0.02)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00 <break></break>(0.00, 0.02)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.059</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.410</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  β-carotene <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.11 <break></break>(0.06, 0.14)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.15 <break></break>(0.10, 0.26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.09 <break></break>(0.00, 0.17)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00 <break></break>(0.00, 0.15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.393</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Total Carotenoids <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72 <break></break>(0.60, 0.88)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.89 <break></break>(0.61, 0.98)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.035</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72 <break></break>(0.44, 0.94)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.54 <break></break>(0.48, 0.80)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.066</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Plasma α-Tocopherol (mg/L) <sup>b</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.1 <break></break>(12.5, 16.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.8 <break></break>(13.6, 16.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.677</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.5 <break></break>(12.8, 17.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.5 <break></break>(11.8, 17.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.761</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.826</td></tr></tbody></table><table-wrap-foot><fn><p>* The <italic>p</italic>-value refers to the change between baseline and eight weeks within each group; <sup>ǂ</sup> ANCOVA was used to compare the change in the F&amp;V concentrate group to the change in the placebo group; <sup>a</sup> mean ± SEM; <sup>b</sup> median (Q1, Q3).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00116-t007" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t007_Table 7</object-id><label>Table 7</label><caption><p>Blood lipids, glycated haemoglobin and systemic inflammation before and after the intervention in subjects with high baseline CRP (≥3.0 mg/mL).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">F&amp;V Concentrate (<italic>n</italic> = 16)</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Placebo (<italic>n</italic> = 15)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ANCOVA <sup>ǂ</sup>
<break></break><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Total Cholesterol (mmol/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.10 <break></break>(5.30, 6.45)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.65 <break></break>(5.40, 6.20)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.30 <break></break>(4.70, 6.70)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.95 <break></break>(4.95, 6.43)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.538</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.549</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>LDL Cholesterol (mmol/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.98 <break></break>(3.37, 4.48)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.82 <break></break>(3.34, 4.33)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.21 <break></break>(2.87, 4.67)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.91 <break></break>(3.22, 4.50)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.279</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.854</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>HDL Cholesterol (mmol/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.30 <break></break>(1.10, 1.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.20 <break></break>(1.13, 1.38)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.656</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.20 <break></break>(1.00, 1.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.20 <break></break>(1.00, 1.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.941</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.804</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Total/HDL Cholesterol</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.90 <break></break>(3.95, 5.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.80 <break></break>(4.40, 5.08)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.324</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.20 <break></break>(4.30, 5.90)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.80 <break></break>(3.95, 5.73)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.398</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.944</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Triglycerides (mmol/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.30 <break></break>(0.98, 2.24)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.41 <break></break>(1.17, 1.82)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.520</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.58 <break></break>(1.16, 1.85)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.77 <break></break>(1.09, 1.91)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.268</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.205</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>HbA1c (mmol/mol)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.0 <break></break>(32.5, 38.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.0 <break></break>(33.0, 37.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.197</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.5 <break></break>(33.8, 40.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.0 <break></break>(33.0, 37.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.783</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.662</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>HbA1c (%)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.40 <break></break>(5.15, 5.60)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.30 <break></break>(5.13, 5.48)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.128</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.45 <break></break>(5.28, 5.83)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.40 <break></break>(5.20, 5.55)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.629</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.284</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>TNFα (pg/mL)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.13 <break></break>(0.95, 1.52)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.95 <break></break>(0.70, 1.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.07 <break></break>(0.79, 1.30)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.96 <break></break>(0.87, 1.26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.632</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.035</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>sTNFR1 (pg/mL)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1140 <break></break>(980, 1491)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1143 <break></break>(988, 1414)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.324</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1294 <break></break>(1047, 1371)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1347 <break></break>(1176, 1442)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.212</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.031</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>sTNFR2 (pg/mL)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2698 <break></break>(2371, 3152)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2389 <break></break>(2205, 3005)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.198</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2554 <break></break>(2313, 2881)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2711 <break></break>(2532, 2998)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Ox-LDL (mU/L)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48,833 <break></break>(43,191, 63,536)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50,719 <break></break>(42,229, 61,437)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.357</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52,683 <break></break>(39,688, 64,661)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45,559 <break></break>(43,009, 62,543)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.536</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.852</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>CRP (mg/mL)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.8 <break></break>(3.6, 9.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.2 <break></break>(3.8, 6.6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.930</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.0 <break></break>(4.1, 7.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.4 <break></break>(3.8, 7.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.820</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.861</td></tr></tbody></table><table-wrap-foot><fn><p>* The <italic>p</italic>-value refers to the change between baseline and eight weeks within each group; <sup>ǂ</sup> ANCOVA was used to compare the change in the F&amp;V concentrate group to the change in the placebo group; all data are presented as the median (Q1, Q3).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00116-t008" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t008_Table 8</object-id><label>Table 8</label><caption><p>Body composition, blood pressure and quality of life before and after the intervention in subjects with high baseline CRP (≥3.0 mg/mL).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">F&amp;V Concentrate (<italic>n</italic> = 16)</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Placebo (<italic>n</italic> = 15)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 Weeks</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value *</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ANCOVA <sup>ǂ</sup>
<break></break><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>BMI (kg/m<sup>2</sup>) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.6 ± 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.5 ± 1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.263</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.2 ± 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.3 ± 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.721</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.531</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Waist circumference (cm) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">113.8 ± 3.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">113.5 ± 3.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.480</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">123.4 ± 3.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">124.3 ± 3.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.806</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.939</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Body Composition</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Total Body Fat (kg) <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.5 ± 2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.6 ± 2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.362</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.9 ± 2.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.2 ± 2.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.345</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.421</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  % Body Fat <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.9 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.9 ± 1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.062</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.7 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.8 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.615</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.069</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Total Lean Mass (kg) <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.1 ± 3.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.9 ± 3.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.049</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.1 ± 3.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.2 ± 3.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.919</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.221</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  % Lean Mass <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.5 ± 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.5 ± 1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.077</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.7 ± 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.7 ± 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.811</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.115</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Android: Gynoid Fat Ratio <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 ± 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 ± 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.892</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 ± 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 ± 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.951</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.996</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Systolic BP (mmHg) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">131.8 ± 3.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129.1 ± 2.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.243</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">140.1 ± 3.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">134.0 ± 3.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.052</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.953</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Diastolic BP (mmHg) <sup>a</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.3 ± 1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.0 ± 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.999</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84.7 ± 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.5 ± 1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.371</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.306</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Pulse (BPM) <sup>b</sup></bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.0 <break></break>(61.5, 71.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71.0 <break></break>(67.0, 78.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.0 <break></break>(63.0, 71.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69.0 <break></break>(62.0, 72.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.988</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.138</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Quality of Life (SF-36)</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Physical <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.9 ± 2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.4 ± 2.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.862</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.4 ± 2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.4 ± 2.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.843</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.665</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">  Mental <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.8 ± 3.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.7 ± 2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.076</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.6 ± 3.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.6 ± 2.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.596</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.259</td></tr></tbody></table><table-wrap-foot><fn><p>BMI: body mass index; BP: blood pressure; * the <italic>p</italic>-value refers to the change between baseline and eight weeks within each group; <sup>ǂ</sup> ANCOVA was used to compare the change in the F&amp;V concentrate group to the change in the placebo group; <sup>a</sup> mean ± SEM; <sup>b</sup> median (Q1, Q3).</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00116-t009" position="float"><object-id pub-id-type="pii">nutrients-09-00116-t009_Table 9</object-id><label>Table 9</label><caption><p>Microarray analysis: biologically-relevant genes that were differentially regulated following F&amp;V concentrate supplementation in subjects with high baseline CRP (≥3.0 mg/mL).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene Name</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene Function</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Fold Change</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-Value</th></tr></thead><tbody><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><underline><bold>Lipogenesis</bold></underline></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>PMVK</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphomevalonate kinase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Catalyses the conversion of mevalonate 5-phosphate into mevalonate 5-diphosphate, the fifth reaction of the cholesterol biosynthetic pathway</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−1.102</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>FDFT1</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Farnesyl-diphosphate farnesyltransferase 1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">First specific enzyme in cholesterol biosynthesis, catalyses dimerization farnesyl diphosphate to form squalene</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>FDPS</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Farnesyl diphosphate synthase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Catalyses the production of intermediates in cholesterol biosynthesis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−1.06</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.034</td></tr><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><underline><bold>NF-κB</bold></underline></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>ZFAND5</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zinc finger, AN1-type domain 5</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits TNF, IL-1 and TLR-induced NF-κB activation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.438</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>ATM</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATM serine/threonine kinase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulates tumour suppressor and DNA repair genes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.242</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>PTGS2</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prostaglandin-endoperoxide synthase 2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Key enzyme in prostaglandin biosynthesis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.199</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.042</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>PARP1</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poly (adenosine diphosphate (ADP)-ribose) polymerase 1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Differentiation, proliferation and tumour transformation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.194</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>PLCG2</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phospholipase C, gamma 2 (phosphatidylinositol-specific)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Catalyses the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), important second messenger molecules</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.161</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.019</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>BCL2</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B-cell chronic lymphoid leukemia (CLL)/lymphoma 2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Important anti-apoptotic protein, classified as an oncogene</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.141</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>TLR4</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toll-like receptor 4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pattern recognition receptor implicated in LPS signal transduction</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.118</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>MAP3K7</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mitogen-activated protein kinase kinase kinase 7</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forms complex with Transforming growth factor beta activated kinase (TAB)-1 or TAB2 which is required for NF-κB</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.112</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.042</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>PRKCQ</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein kinase C, theta</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Important for T-cell activation and NF-κB transcription factor activation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.082</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.020</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>PRKCB</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein kinase C, beta</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphorylates protein targets involved in B cell activation, apoptosis, endothelial cell proliferation, intestinal sugar absorption</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.072</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.048</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>MALT1</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mucosa-associated lymphoid tissue lymphoma translocation protein 1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Proteolytic activity, many targets involved in regulation of inflammation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.067</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.028</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>TNFAIP3</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tumour necrosis factor-induced protein 3</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced by TNF, inhibits NF-κB and TNF-mediated apoptosis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.059</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.042</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold><underline>AMPK</underline></bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>CAB39</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Calcium binding protein 39</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stimulates STK11 activity, which is an upstream kinase of AMPK</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.418</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>RAB10</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RAB10; RAS oncogene family</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulates intracellular vesicle trafficking</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.279</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.020</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>SIRT1</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sirtuin 1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Involved in regulating AMPK expression</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.152</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.019</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>IRS2</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insulin receptor substrate 2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mediates effects of insulin, insulin-like growth factor 1, and cytokines</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.137</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>RHEB</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ras homolog enriched in brain</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">involved in the mechanistic targeting of rapamycin (mTOR) pathway and the regulation of the cell cycle</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.119</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.048</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>MAP3K7</bold></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mitogen-activated protein kinase kinase kinase 7</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forms complex with TAB1 or TAB2, which is required for NF-κB</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.112</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.042</td></tr></tbody></table></table-wrap></floats-group></article>